title: CommaD cultered cells, in-vivo 5 weeks, biological rep3

source_name: in-vitro CommaD injected mammary tissue after 5 weeks

tag: cell line

value: CommaD

value: CommaD-injected mammary tissue

tag: vivo/vitro

value: in-vivo

tag: weeks


title: DNA_AS_STN2_150m 2

status: Public on Oct 19 2018

type: genomic

city: Princeton

first: Bess

middle: B

last: Ward

state: NJ

address: Washington Road

department: Geosciences

country: USA

institute: Princeton University

description: environmental DNA extracted seawater

hyb_protocol: Samples were hybridized to duplicate arrays by overnight incubation at 64°C and washed.

scan_protocol: The arrays were scanned with a laser scanner (Molecular Devices 4300) Images were analyzed with Gene Pix Pro 6.0 software (Molecular Devices)

data_processing: Quality control was employed to remove noise by eliminating features in which the Cy3 signal was not at least twice the value of the control probes.

molecule: genomic DNA

organism: synthetic construct

source_name: 70-mer probe

label_protocol: The genomic DNA was amplified with PCR primers NOSZ1R and NOSZ1F, and labeled with amino-allyl-dUTP (Ambion) during linear amplification using random octamers and a Klenow polymerase (Applied Biosystems). The reaction contained 3.96 mM d(AGC)TP, 0.44 mM dTTP, and 4.84 mM dUaa and was amplified for 3 h at 37°C. The Klenow product was purified and conjugated with Cy3. The Cy3-labelled target (200 ng) was combined with 2x hybridization buffer (1x final concentration; Agilent) and 0.25 pmol of a Cy5-labelled complementary 20-mer standard oligonucleotide and incubated at 95°C for 5 min before being cooled to room temperature.

extract_protocol: DNA was extracted from the filters using the PureGene DNA kit (Gentra, Minneapolis, MN) or the AllPrep DNA/RNA Mini Kit (Qiagen Sciences, Maryland, USA) with slight modifications (as in Ward 2008).

tag: sample type

value: 20-mer DNA oligo

organism: seawater metagenome

source_name: PCR fragment amplified from total DNA extract

tag: location

value: water column Arabian Sea


title: Donor 5 CTRL

type: SRA

city: Rozzano, Milan

first: Emilia Maria Cristina

last: Mazza

address: Via Alessandro Manzoni, 56

country: Italy

institute: Humanitas Clinical and Research Center

library_source: transcriptomic

data_processing:
Basecall was performed using CASAVA version 1.8
RNA-seq reads were aligned to the GRCh38 genome assembly using STAR version 2.5.1b
Raw gene counts were generated from STAR output and normalized in TPM counts
Differential Gene Expression analysis was performed using EdgeR 3.22.1 R version 3.3.3 . False discovery rate < 0.05
Genome_build: GRCh38
Supplementary_files_format_and_content: raw_counts

molecule: total RNA

organism: Homo sapiens

source_name: human CD8 T cells_control

growth_protocol: human naive T cells from human healty donors were put in culture for 8 days in presence of culture medium and interleukins 2 and 12 with CD3/CD28 antibody-conjugated  beads

extract_protocol:
Total RNA extraction with RNeasy Micro Kit (Qiagen), 2 ng of total RNA were udes for the construction of sequencing libraries.
RNA libraries were prepared for sequencing using Nextera XT DNA Library Preparation Kit

tag: donor id

value: healty donor 5

tag: cell type

value: human CD8 T cells

tag: treated with

value: none (control)


title: macroangiopathy_muscle_3

type: RNA

city: harbin

first: Xiaoting

last: Li

address: haerbindajie

country: China

institute: Biotechnology

hyb_protocol: Each Slide was hybridized with 1.65g Cy3-labeled cRNA using Gene Expression Hybridization Kit (Cat#5188-5242, Agilent technologies, Santa Clara, CA, US) in Hybridization Oven (Cat#G2545A, Agilent technologies, Santa Clara, CA, US), according to the manufacturers instructions.

scan_protocol: Slides were scanned by Agilent Microarray Scanner (Cat#G2565CA, Agilent technologies, Santa Clara, CA, US) with default settings, Dye channel: Green, Scan resolution=5m, PMT 100%, 10%, 16bit.

data_processing: Data were extracted with Feature Extraction software 10.7 (Agilent technologies, Santa Clara, CA, US). Raw data were normalized by Quantile algorithm, Gene Spring Software 11.0 (Agilent technologies, Santa Clara, CA, US).

organism: Mus musculus

label_protocol: Low Input Quick Amp Labeling Kit

extract_protocol: Total RNA was amplified and labeled by Low Input Quick Amp Labeling Kit, One-Color (Cat#5190-2305, Agilent technologies, Santa Clara, CA, US), following the manufacturers instructions. Labeled cRNA were purified by RNeasy mini kit (Cat#74106, QIAGEN, GmBH, Germany).

tag: tissue

value: Skeletal muscle


title: CNS3

city: Stockholm

first: Ewoud

last: Ewing

address: CMM L8:05, Karolinska University Hospital

department: Clinical Neuroscience

country: Sweden

institute: Karolinska Institutet

hyb_protocol: standard Illumina protocol

scan_protocol: standard Illumina protocol

data_processing: Basically we only read the conserved probes between mouse and human, resulting in 18400 probes being read. This pipeline is an adaptation of the ChAMP pipeline. As for normalization, this mEPIC pipeline, as described in the paper https://www.ncbi.nlm.nih.gov/pubmed/29141580

label: Cy5, Cy3

source_name: Repopulated proliferating microglia (F4/80low) in Cx3cr1CreER/+R26DTA/+ mice, 7 weeks after Tamoxifen

label_protocol: standard Illumina protocol

extract_protocol: DNA was extracted using QIAamp DNA micro kit from Qiagen.

treatment_protocol: Naive cells were sorted from completely naive mice or TAM treated Cx3cr1CreER/+ control mice. Cx3cr1CreER/+R26DTA/+ mice were treated with Tamoxifen (TAM) on three consecutive days and cells sorted from the CNS on the indicated weeks.

tag: strain

tag: treatment

value: Tamoxifen

value: Brain

tag: sorting strategy


title: SHENQI_aorta_1

value: aorta


title: Donor 4 CTRL

value: healty donor 4


title: CNS1 rep


title: macroangiopathy_muscle_1


title: CNS2


title: Donor 2 CTRL

value: healty donor 2


title: macroangiopathy_muscle_2


title: DNA_AS_STN2_150m 1

description: environmental DNA extracted seawater


title: DNA_AS_STN1_175m 2

description: environmental DNA extracted seawater


title: DNA_AS_STN1_175m 1

description: environmental DNA extracted seawater


title: macroangiopathy_aorta_3


title: DNA_AS_STN1_150m 2

description: environmental DNA extracted seawater


title: CNS1


title: macroangiopathy_aorta_2


title: L44

source_name: Repopulated proliferating microglia (F4/80low) in Cx3cr1CreER/+R26DTA/+ mice, 4 weeks after Tamoxifen


title: diabetic_muscle_3


title: L29


title: macroangiopathy_aorta_1


title: Donor 3 CTRL

value: healty donor 3


title: Naive 2

source_name: Naive microglia

value: Naive


title: DNA_AS_STN1_150m 1

description: environmental DNA extracted seawater


title: diabetic_muscle_2


title: DNA_ETSP_STNBB2_300m 2

description: environmental DNA extracted seawater

value: water column Eastern Tropical South Pacific Ocean


title: diabetic_muscle_1


title: DNA_ETSP_STNBB2_300m 1

description: environmental DNA extracted seawater


title: Donor 1 CTRL

value: healty donor 1


title: diabetic_aorta_3


title: Naive 1


title: DNA_ETSP_STN55_175m 2

description: environmental DNA extracted seawater


title: DNA_ETSP_STNBB_115m 1

description: environmental DNA extracted seawater


title: Slide US45102948_256525610010_S03.5

city: STOCKHOLM

first: Sulman

last: Shafeeq

address: nobel vag 16

department: MTC

description: Sample 1

hyb_protocol: The protocol was performed as described in Kloosterman et al., 2006 and Shafeeq et al., 2011.

scan_protocol: Scanning was done using the Genepix 4200AL laser scanner.

data_processing: Dual-channel array images were analyzed with Genepix 6.  Spots were screened visually to identify those of low quality. Slide data were processed with MicroPreP software. Prior to analysis, automatically and manually flagged spots and spots with very low background subtracted signal intensity (5% of the weakest spots [sum of Cy3 and Cy5 net signals]) were filtered out of all data sets. Net signal intensities were calculated by grid-based background subtraction. A grid-based Lowess transformation was performed for slide normalization, negative and empty values were removed, and outliers were removed by the deviation test. Expression ratios  were calculated. Further analysis was performed with a Cyber-T Student T-test for paired data.

organism: Streptococcus pneumoniae D39

source_name: F635 Mean

label_protocol: Total RNA was incubated for 16 h at 42°C in the presence of 400 U Superscript III RNase H reverse transcriptase (Invitrogen), 0.2 mM aminoallyl dUTP (Amersham), 0.5 mM dATP, 0.5 mM dCTP, 0.5 mM dGTP, 0.3 mM dTTP, and 3.2 g random nonamers. The synthesized cDNA was then labeled by coupling either Cy3 or Cy5 to the dUTP aminoallyl reactive group (CyScribe postlabeling kit; Amersham Biosciences) and was purified using a GFX PCR, DNA, and gel band purification kit (Amersham Biosciences).

growth_protocol: Cells were grown in CDM supplemented  with 55 mM mannose. Cells were grown until early exponential phase. This corresponded to OD600 of 0.3.

extract_protocol: RNA was isolated and purified using the High Pure RNA isolation kit (Roche diagnostics) as described (Kloosterman et al., 2006). Contaminating genomic DNA was removed by treatment with RNase-free DNase I (Roche diagnostics). RNA was isolated from three replicate cultures.

tag: genotype

value: wild-type

source_name: F532 Mean

value: spd_0144 mutant


title: DNA_ETSP_STN55_175m 1

description: environmental DNA extracted seawater

value: 20-mer DNA oligo


title: DNA_ETNP_STNBB2_140m 2

description: environmental DNA extracted seawater

value: water column Eastern Tropical North Pacific Ocean


title: RPM5

source_name: Red pulp macrophage

value: Spleen


title: DNA_ETSP_STNB2B_115m 2

description: environmental DNA extracted seawater


title: RNA of 50 mg/L BPA treatment, biological rep2

city: Istanbul

first: Ceyhun

last: Bereketoglu

address: Goztepe

country: Turkey

institute: Marmara University

description: Gene expression data from yeast RNA

hyb_protocol: The purification and fragmentation steps were carried out using GeneChip reagents and fragmented aRNA was assessed using Agilent 2100 Bioanalyzer (Agilent Technologies). A total of 5 µg of aRNA was hybridized on arrays for 16-h at 45⁰C.The arrays were then loaded into a fluidics station for washing and staining using Aﬀymetrix Command Consoles Software (AGCC) 3.0.1 Fluidics Control Module with Mini_euk2v3.

scan_protocol: Arrays were scanned on an Aﬀymetrix GeneChip Scanner 3000.

data_processing: CEL files obtained from the analyzed arrays were normalized via quantile normalization using RMA as applied in the affy package of R/Bioconductor suite of tools for the analysis of transcriptomics data. Significantly expressed genes were identified from the normalized log-expression values using the multiple testing option of LIMMA .

label: biotin

organism: Saccharomyces cerevisiae

source_name: RNA of yeast cells exposed to 50 mg/L BPA for 180 minutes

label_protocol: 100 ng of total RNA was used to synthesize first-strand cDNA and the first-stranded cDNA was converted into a double-stranded DNA with GeneChip 3’ IVT Express Kit (Affymetrix Inc). In vitro transcription and synthesis of biotin-labelled aRNA were performed using the double-stranded DNA as a template.

growth_protocol: YPD broth was inoculated with 1% of yeast pre-culture and incubated at 30⁰C, 180 RPM in incubator shaker

extract_protocol: Extraction of total RNA was performed with RNeasy Mini Kit (Qiagen) according to the manufacturer's instructions.

treatment_protocol: Cultures at mid-exponential phase were treated with 50 mg/L and 300 mg/L BPA prepared in ethanol while controls were treated with the same volume of ethanol for 180 minutes.

tag: cells

value: Yeast cells


title: RNA of 50 mg/L BPA treatment, biological rep1

description: Gene expression data from yeast RNA


title: control RNA, biological rep3

description: Gene expression data from yeast RNA

source_name: RNA of yeast cells exposed to no BPA for 180 minutes


title: RNA of 300 mg/L BPA treatment, biological rep3

description: Gene expression data from yeast RNA

source_name: RNA of yeast cells exposed to 300 mg/L BPA for 180 minutes


title: RNA of 300 mg/L BPA treatment, biological rep2

description: Gene expression data from yeast RNA


title: diabetic_aorta_1


title: RPM4


title: Ly6C 3

source_name: Ly6Chi monocyte

value: Bone marrow

value: MACS BM mononcyte kit


title: DNA_ETNP_STNBB2_140m 1

description: environmental DNA extracted seawater


title: healthy_muscle_2

value: Skeletal muscle


title: Ly6C 2


title: Ly6C 1


title: Ly6C 3 rep


title: healthy_muscle_1


title: RNA of 50 mg/L BPA treatment, biological rep3

description: Gene expression data from yeast RNA


title: healthy_muscle_3


title: cMOP 4

source_name: Common monocyte progenitor


title: diabetic_aorta_2


title: DNA_Antarctic_60m 2

description: environmental DNA extracted seawater

value: water column Antarctic Ocean


title: RNA of 300 mg/L BPA treatment, biological rep1

description: Gene expression data from yeast RNA


title: healthy_aorta_3

value: aorta


title: control RNA, biological rep2

description: Gene expression data from yeast RNA


title: healthy_aorta_2


title: DNA_Antarctic_60m 1

description: environmental DNA extracted seawater


title: LAA

city: Amsterdam

first: Vincent

middle: M.

last: Christoffels

state: N/A (NA)

address: Meibergdreef 15  K2-159

department: Medical Biology

country: Netherlands

institute: Amsterdam UMC

data_processing:
The reads were trimmed with ILLUMINACLIP:./adapters_list_v6.fa:2:40:15 MINLEN:15
Using HISAT2 (v2.0.4), the reads were aligned to the genome.
Counts are obtained using HTSeq (v0.6.1)
Statistical analyses are performed using the edgeR (Robinson et al., 2010) and limma/voom (Ritchie et al., 2015) R packages.
All genes with no counts in any of the samples are removed whilst genes with more than 5 reads in at least 2 of the samples are kept.
Count data are transformed to log2-counts per million (logCPM), normalized by applying the trimmed mean of M-values method (Robinson et al., 2010) and precision weighted using voom.
Differential expression is assessed using an empirical Bayes moderated t-test within limma’s linear model framework including the precision weights estimated by voom. Resulting P values are corrected for multiple testing using the Benjamini-Hochberg false discovery rate. Genes are re-annotated using biomaRt using the  Ensembl genome databases (v91).
Genome_build: Genome and GTF were obtained from Ensembl (v0.89): OryCun2.0 (assembly GCA_000003625.1) and Oryctolagus_cuniculus.OryCun2.0.89.asFasta.gtf, respectively.
Supplementary_files_format_and_content: Excel file with counts

organism: Oryctolagus cuniculus

source_name: Left atrial appendage

extract_protocol:
Tissue samples were snap frozen in liquid nitrogen, RNA was extracted using Trizol and further purified using the Nucleospin RNA XS kit. For library preparation, 450 ng of RNA was used.
The Truseq Stranded Total RNA protocol was used for library preparation. Cytoplasmic and mitochondrial rRNA was depleted using Ribo-Zero Gold. 10 PCR cycles were performed to amplify the cDNA

value: heart

tag: heart region

value: Left atrial appendage

tag: breed

value: New Zealand White Rabbit


title: control RNA, biological rep1

description: Gene expression data from yeast RNA


title: GMP 2

source_name: Granulocyte macrophage progenitor

value: Naive


title: LAFW

source_name: Left atrial free wall

value: Left atrial free wall


title: healthy_aorta_1


title: DNA_Arctic_40m 2

description: environmental DNA extracted seawater

source_name: 70-mer probe

value: water column Arctic Ocean


title: DNA_Arctic_40m 1

description: environmental DNA extracted seawater

source_name: PCR fragment amplified from total DNA extract


title: MV_PROM_3

status: Public on Oct 18 2018

city: Edinburgh

first: nick

last: gilbert

address: Crewe Rd

department: MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine

country: United Kingdom

institute: University of Edinburgh

library_source: genomic

data_processing:
Trim Galore (v0.4.1) was used to remove adapter sequence from paired end fastq files.
Trimmed reads were “in silico digested” using a custom script to split fastq records at GATC; for each paired end read this gives a group of shorter sequences.
Bowtie (v 1.1.1) was used to map each fragement in “single end” mode.
Groups of mapped fragments originating from the same pair of reads were identified, and a custom script used to remove duplicates, and identify target-report pairs.
Custom scripts were used to generate pile-ups of informative reads, and generate binned and smoothed interaction profiles for each target.
Genome_build: mm9
Supplementary_files_format_and_content: BedGraphs of raw pile-up of interactions, and binned and smoothed interaction profiles for each target.

source_name: MV+ cells

growth_protocol: β-TC3, MV+ and RAG cells were cultured in Dulbecco’s Modified Eagle Medium (ThermoFisher) supplemented with 10% fetal calf serum and 1% Penicillin-Streptomycin at 37°C in 5% CO2

extract_protocol:
Cells were further lysed by re-suspension in water, and then in 0.5 % SDS at 62 C for 10 min. Each replicate was split between three tubes, re-suspend in 800 l 1 DpnII buffer (NEB) with 1.6 % TritonX100, and digested with 3 sequential additions of 750 units DpnII enzyme at 37 C 1200rpm over 24 hours. Samples were heat inactivated at 65 C for 20 min, and 3 samples from each replicate combined into 7 ml with 1T4 DNA Ligase Buffer (NEB), with 1 % TritonX100, and 12,000 units of T4 DNA ligase at 16 C overnight. Samples were treated with Protinease K at 65 C overnight and RNase A/T1 (ThermoFisher) at 37 C for 1 hour, before a standard Phenol Chloroform/Chloroform extraction and ethanol precipitation was performed. Complete digestion and ligation was assessed by gel electrophoresis. Purified 3C DNA from each sample was sonicated to 200-400 bp with a Soniprep 150 probe sonicator at 4 C, and purified with a standard Ampure XP Bead protocol (Beckman Coulter) using a 1/1.5 DNA to bead ratio.  Two Illumina sequencing libraries were prepared per capture pool replicate, with 6 g of starting DNA in each, and generated using NebNext DNA Library Prep Kit (NEB), with samples indexed with unique barcodes using NebNext Multiplex Oligos for Illumina (NEB). Two separate capture pools were designed to the following Pax6 locus elements: CTCF/Cohesin binding sites, known and predicted enhancer clusters, and the multiple promoters of three genes in the locus Pax6, Elp4 and Rcn1 (a full list of targeted restriction enzyme fragments is given in Suppl. Table 1). Capture oligos were designed to each end of the targeted DpnII fragments as described by in Ref. (Davies, 2016), and each synthesised as a separate 4 nM reaction, with a 5 Biotin label on a 120 bp Ultramer (IDT). All capture oligos from each of the two capture pools were mixed at equimolar amounts and pooled to a final concentration of 13 pmol in a volume of 4.5 l per sequence capture. Libraries where sized and quality controlled on a D1000 Tapestation tape (Agilent).
NG Capture-C sequence capture was performed using SeqCap EZ HE-Oligo Kit A or B (dependent on the multiplex barcode) and SeqCap EZ Accessory Kit (Nimblegen) as described in Ref. (Davies, 2016), using each of the two capture pools, with 1.5-2 g 3C library DNA per hybridisation reaction. Each hybridisation reaction was performed on a thermocycler at 47 C and incubated for between 66 and 72 hours. Each hybridisation reaction was then bound to streptavidin beads from SeqCap EZ Pure Capture Bead Kit and washed with SeqCap EZ Hybridization and Wash Kit (Nimblegen), following the manufacture's protocol. Hybridization reactions were split into two and libraries re-amplified using Post LM-PCR oligos (Nimblegen) and Q5 High-Fidelity DNA polymerase (NEB) directly from the beads, and then the DNA was purified using Ampure XP Bead 1/1.8 DNA to bead ratio. A second hybridisation reaction was performed as above on the re-amplifed 3C libraries with two reactions pooled together (∼1 g in each) and incubated for 22-24 hours. Washed and re-amplified double captured libraries where sized and quality controlled on a D1000 Tapestation tape (Agilent), and paired-end sequenced on an Illumina Hi-seq 2500 or Hi-seq 4000.
Capture-C

treatment_protocol: Two replicates of  cells where processed for each cell type, fixed with 2 % formaldehyde, and lysed for 15 min with standard 3C lysis buffer before snap freezing at -80 °C.

value: MV+


title: RAG_PROM_4

source_name: RAG cells

value: RAG


title: RAG_CTCF_3


title: MV_PROM_4


title: MV_CTCF_4


title: circRHOT1_WT

city: Guilin

first: b

address: Lequn road No.15

department: Gastrointestinal Department

institute: Affiliated Hospital of Guilin Medical University

data_processing:
RNA-seq was performed using a BGISEQ-500 platform and the raw reads were filtered for adaptor sequence, masked for low-complexity or low-quality sequence.  Clean reads were mapped to hg19 using HISAT/Bowtie2 tool.Gene expression level was qantified by RSEM and FPKM was calculated.RNA-seq analysis was completed by BGI company(Shenzhen,China)
Genome_build: hg19
Supplementary_files_format_and_content: tab-delimited text files include RPKM values for each Sample ...

source_name: HCC cells

growth_protocol: HCC cells were cultured in DMEM medium supplemented with 20 % FBS, 2 mM glutamine, 1 mM pyruvate, 10 mM HEPES, 100 units/mL penicillin/streptomycin, 0.1 mg/mL gentamicin, and 2 g/L Fungizone

extract_protocol:
Total RNA isolated using Trizol reagent (Ambion). Single-ended 50 bp reads (59 million per sample on average) were generated using a BGISEQ-500 platform (BGI America Co., Cambridge, MA).
Construction of RNA-seq library was completed by BGI company (Shenzhen,China).

treatment_protocol: HCC cells were infected with CRISPR/Cas Lentivirus containging circRHOT1-sgRNAs. circRHOT1-deficient HCC cells were screened out.

value: hepatocellular carcinoma (HCC) cells

tag: genotype/variation

value: wild type

tag: tnm stage

value: III


title: circRHOT1_KO

value: circRHOT1 knockout


title: MV_CTCF_3

tag: cell line


title: CMP 1

source_name: Common myeloid progenitor

value: Bone marrow


title: RAG_CTCF_4


title: yangyinyiqi_aorta_3

description: Formula of SHENQI compound


title: 4_10314vd-763_T_poumon

city: Montreal

first: Krystel

last: Vincent

state: Quebec

address: 2950, chemin de la Polytechnique, Marcelle-Coutu Pavilion

country: Canada

institute: Institute for Research in Immunology and Cancer

data_processing:
Basecalls performed using bcl2fastq version 2.19
Sequenced reads were trimmed for sequencing adapters and low quality extremities using Trimmomatic version 0.35
Expression values were estimated using kallisto version 0.43.0 for each sample with replicates pooled into one sample
Genome_build: GRCh38 using transcript annotations from Ensembl 88
Supplementary_files_format_and_content: Tab-delimited files where columns are described in the header and are standard kallisto output: Ensembl transcript identifier, transcript length, eff_length, estimated counts, TPM values.

molecule: polyA RNA

source_name: lung tumor biopsy

extract_protocol:
AllPrep DNA/RNA/miRNA Universal kit (Qiagen, #80224)
KAPA RNA Stranded PolyA

tag: tissue type

value: primary tumor sample

tag: tumor type

value: lung tumor biopsy

tag: short name


title: RAG_PROM_3


title: 2_11974vd-811_T_poumon


title: PLC_10H118

source_name: B-ALL

extract_protocol:
TriZol + RNeasy mini Kit (Qiagen, #74106)
KAPA RNA Stranded PolyA

value: B-ALL


title: PLC_10H080


title: PLC_07H103


title: 6-2816vd-148_T_poumon


title: CMP 2


title: 2M-Sca1+_2

city: Irvine

first: Maksim

middle: V

last: Plikus

state: California

address: 845 Health Sciences Road

department: Developmental and Cell Biology

institute: University of California, Irvine

data_processing:
Sequenced reads were mapped to gencode version M4 of mouse (mm10) using bowtie v1.0.0 with the following standard parameters: rsem-calculate-expression -p $CORES --paired-end
Paired-end reads were aligned to the mouse genome (mm10/gencode.vM4) with bowtie aligner (version 1.0.0) and quantified using the RNA-seq by Expectation-Maximization algorithm (RSEM) (version 1.2.12) with the following standard parameters: rsem-calculate-expression -p $CORES --paired-end 3. Samples displaying >12,000,000 aligned reads and >77% alignment were considered for downstream analyses. Samples were filtered using Python and only protein-coding genes and lncRNAs expressed at minimum 1 TPM in at least one sample in all biological replicates were considered for downstream analyses.
Differential expression dynamics across E14, E17, P1-Sca1+, P20-Sca1+ P60-Sca1+ samples was identified using the single-time series, two-step regression model algorithm Next maSigPro using with the following parameters under the T.Fit,  get.siggenes and see.genes functions: alfa = 0.01, vars=”all”, rsq = 0.7, k=7 4,5.
Genome_build: mm10
Supplementary_files_format_and_content: tab-delimited text file includes TPM values

source_name: Skin dermis

growth_protocol: Primary dermal fibroblast (passage1) were cultured in DMEM supplemented with FBS and antibiotics

extract_protocol:
Trizol was used to extract total RNA from cells
Sca1+ P1~2M cells  were purified using anti-Sca1 microbeads kit (Mitenyi Biotech)
SMART-seq2 was performed as previously described with minor modifications (Picelli et al 2014a; Picelli et al. 2014b). Briefly, 10 ng total RNA from viable, sorted cells was reversed transcribed for 10 cycles as previously suggested using Super Script II (Invitrogen). cDNA was pre-amplified for 15 cycles using high fidelity KAPA HiFi HotStart Ready Mix (Kapa Biosystems). Pre-amplified cDNAs were cleaned with AMPure XP beads (Beckman Coulter) at a 1:1 ratio and eluted with elution buffer (Qiagen). Tn5-mediated tagmentation was performed on 18 ng total cDNA using the Nextera DNA Sample Preparation Kit (Illumina) at 55°C for 5 minutes and deactivated with PM buffer (Qiagen). Adapter-ligated fragments were amplified for 8 continuous cycles using universal Ad1 and unique Ad2.xx barcodes (IDT). Amplified PCR fragments were purified with AMPure XP beads as suggested (Beckman Coulter). Size selected libraries were quantified using Qubit (Thermo), loaded on a High-Sensitivity DNA chip for quality control (Agilent), and quantified using KAPA for Illumina Sequencing Platforms (Illumina). Libraries were multiplexed and sequenced as paired-end, 43 bps on a NextSeq 500 Illumina Sequencing Platform (Illumina).

value: Wild type

tag: age

value: Skin

value: Skin fibroblasts/pre-adipocytes


title: PLC_12H018


title: 2M-Sca1+_3

tag: cell type


title: 2M-Sca1+_1


title: 3W-Sca1+_3


title: 3W-Sca1+_2


title: 3W-Sca1+_1


title: P1-Sca1+_2


title: P1-Sca1+_1


title: E17_3


title: E17_2


title: E14_1


title: E14_3


title: E17_1


title: E14_2


title: OVX VV Veh 3

city: New York

first: Nathan

last: Einhorn

state: NY

address: 1230 York Avenue

department: Laboratory of Neuroendocrinology

institute: The Rockefeller University

data_processing:
Illumina NextSeq 500
Raw reads were trimmed to remove sequencing artefacts (10bp from 5’ end) and filtered to remove low quality reads (read with a quality score < 20 in more than 10% of bases were discarded)
Aligned to mouse genome (mm10) using TopHat2
Differential expression analysis was conducted with Strand NGS software (Agilent Technologies,USA), in which DESeq was used to quantify transcript reads and obtain Z scores and fold change values for individual genes. Genes with p<0.05, Benjamini-Hochberg corrected and fold change greater than 1.3 were selected for further analysis
To compare the human and mouse genomes, a DESeq2 analysis pipeline through R was used to quantify both species’ raw reads and obtain p-values and log fold changes. Using Microsoft Excel, human genes were matched to their mouse orthologues and filtered with an uncorrected p<0.05. Human data is sourced from Dubey et al. 2017 (doi: 10.1038/mp.2016.229) and will not be apart of this upload. It can be accessed upon reasonable request to the authors
Genome_build: mm10
Supplementary_files_format_and_content: Raw counts and counts per million of genes

source_name: ventral hippocampus of ovariectomized female mice

extract_protocol:
After 6 weeks of treatment, Mice were killed by cervical dislocation and rapidly decapitated to extract the ventral hippocampi.
A total of 200ng of RNA per group was prepared for sequencing by The Rockefeller University Genomics Core Facility using the Tru-Seq Stranded RNA-Seq library preparation kit (Illumina, USA). Three biological replicates were used per experimental group, comprising of RNA pooled from 2 animals each. cDNA libraries were sequenced on an Illumina NextSeq 500 in a single lane to obtain 75-bp single-end reads at an approximate sequencing depth of 35-40 million reads per sample.

treatment_protocol: Mice were ovariectomized and allowed to recover for 2 weeks before E2 treatment. WT and Het-Met mice were treated with either 300 nM β-E2 in 0.1% ethanol (0.7 ug/day), or with 0.1% ethanol (vehicle) solution, administered ad libitum in cage water bottles for 6 weeks.

tag: Sex

value: Female

value: Wild Type

value: Ventral Hippocampus

value: Vehicle


title: OVX VM E2 1

value: BDNF Met/+

tag: tissue

value: Estradiol


title: OVX VV E2 1

tag: strain


title: OVX VM E2 3

tag: treatment


title: OVX VM Veh 1


title: OVX VM Veh 2


title: OVX VM E2 2


title: OVX VM Veh 3


title: HPMC_TGF-b1_6hr

city: Gwangju

first: Joo Young

last: Huh

address: 77 Yongbong-ro

department: College of Pharmacy

country: South Korea

institute: Chonnam National University

description: Gene expression of TGF-b1 treated cells after 6hr

hyb_protocol: Biotin-labeled cRNA was labeled with Cy3 (Amersham, Piscataway, NJ, USA) and hybridized onto a HumanRef-8 24 K Expression Array Bead Chip (Illumina, San Diego, CA, USA).

scan_protocol: The arrays were then scanned by an Illumina Bead Station laser scanning imaging system.

data_processing: The data were analyzed using Genespring software from Agilent after normalization.

label_protocol: For microarray analysis, 0.5 mg of total RNA was used to make biotin-labeled cRNA using the Ambion Illumina cRNA amplification and labeling kit (Ambion, Austin, TX, USA) . cRNA was then column purified and the quality verified by Agilent 2100 Bioanalyzer (Palo Alto, CA, USA) prior to hybridization.

growth_protocol: Human omentum tissue was obtained from consenting patients undergoing abdominal surgery. HPMCs were isolated by enzymatic disaggregation with 0.25 % trypsin–EDTA, and then cells were maintained in Medium 199 (M199) supplemented with 20 % fetal bovine serum (FBS) at 37 °C in a humidified atmosphere of 5 % CO 2 and 95 % air.

extract_protocol: Total RNA extracted using Trizol following manufacturer's instructions.

treatment_protocol: For experiments, cultured HPMCs were seeded at 80 % confluence in M199 containing 20 % FBS for 24 h and then incubated with serum-free medium to arrest and synchronize cell growth. The cells were then exposed to recombinant human TGF-1 (R&D Systems, Inc., Minneapolis, MN).

value: human peritoneal mesothelial cells (HPMC)

tag: time-point


title: HPMC_control_6hr

description: Gene expression of control cells after 6hr


title: HPMC_control_24hr

description: Gene expression of control cells after 24hr


title: OVX VV Veh 1

tag: genotype


title: P1-Sca1+_3


title: OVX VV E2 2


title: HPMC_TGF-b1_24hr

description: Gene expression of TGF-b1 treated cells after 24hr


title: 6499c4 Vehicle

city: Philadelphia

first: Brian

middle: C.

last: Capell

state: PA

address: 421 Curie Boulevard Biomedical Research Building 1020 Biomedical Research Building 1020

department: Dermatology

institute: University of Pennsylvania

data_processing: All RNA-seq data was processed in the following manner: Single end data was aligned using RNA STAR and FPKM generation and differential expression analysis was performed DESeq2 using default settings of Illumina BaseSpace.

growth_protocol: murine PDAC cells (obtained from the Stanger Lab, University of Pennsylvania) were grown in DMEMl, with 5% FBS and 1% Antibiotic-Antimycotic at 5% CO2

extract_protocol:
RNA was extracted using RNeasy kit (Qiagen catalog no. 74014) and following the manufacturer’s instructions.
NEBNext® Ultra™ RNA Library Prep Kit for Illumina

treatment_protocol: Cells were treated with vehicle (DMSO) or 250nM G-1 (Cayman Chemical,Ann Arbor, MI, USA) for 16 hours prior to RNA extraction.

value: murine pancreatic ductal adenocarcinoma

tag: passages


title: 6419c5 Vehicle


title: 6419c5 250nM G-1


title: 6499c4 250nM G-1


title: 2838c3 250nM G-1


title: 2838c3 Vehicle


title: BALB-c_mTEChi_2

data_processing:
Basecalls performed using CASAVA-1.8.2 for HiSEQ 2000 data and bcl2fastq version 2.19 for NextSeq 500 data
Sequenced reads were trimmed for sequencing adapters and low quality extremities using Trimmomatic version 0.35
Expression values were estimated using kallisto version 0.43.1 for each sample with replicates pooled into one sample
Genome_build: GRCm38 using transcript annotations from Ensembl 87
Supplementary_files_format_and_content: Tab-delimited files where columns are described in the header and are standard kallisto output: Ensembl transcript identifier, transcript length, eff_length, estimated counts, TPM values.

source_name: mature medullary thymic epithelial cells

extract_protocol:
KAPA RNA HyperPrep PolyA
TriZol + RNeasy mini Kit (Qiagen, #74106)
see SAMPLES section

value: Balb/c

value: thymus

value: 5-8 weeks

value: mTEChi


title: BALB-c_mTEChi_3


title: BALB-c_mTEChi_1


title: Nalm6_RNAseq_C24: shHP1g dex replicate 3

city: Los Angeles

middle: Hae Kang

last: Lee

state: CA

address: 1441 Eastlake Avenue, NOR 6316

department: Biochemistry and Molecular Medicine

institute: University of Southern California

data_processing:
NextSeq Control Software (NCS) v1.4 was used for base calling
After trimming the raw reads for quality and adapter sequence, the samples were mapped using HISAT2 with default parameters against the GRCh37/hg19 human reference genome
Mapped reads were quantified to known UCSC genes using the GenomicAlignments R package
Gene expression levels were normalized with the upper quantile (UQ) method and lowly expressing genes were excluded such that genes with more than one count per million in at least 2 samples were analyzed
We implemented the remove unwanted variation (RUV) strategy to account for unknown nuisance technical effects between samples.
Differentially expressed genes were identified with edgeR using a fold change cutoff when indicated and false discovery rate adjusted p-value ≤ 0.05.
Genome_build: hg19
Supplementary_files_format_and_content: comma separated file (csv) containing log2 fold change and FDR values for the comparisons made in the columns and each row representing a gene

source_name: Nalm6 cells

growth_protocol: Cells were maintained in RPMI 1640 medium containing L-Glutamine and 10% fetal bovine serum at 37°C and 5% CO2

extract_protocol:
Total RNA was extracted using TRIzol (Thermo Scientific) and 3 biological replicates for each condition were performed on different days.
RNA samples were reverse transcribed using Superscript III (ThermoFisher) and quality of the cDNA was assessed using Agilent Technologies 2100 Bioanalyzer and RT-qPCR analysis was performed for selected GR target genes as quality control. Standard illumina protocols were used to construct the library for sequencing.

treatment_protocol: Nalm6 cells depleted for G9a, GLP or HP1γ using shRNA were incubated with 100 nM of Dexamethasone (Dex) or equivalent volume of vehicle ethanol for 8 h.

value: acute lymphoblastic leukemia cell line


title: Nalm6_RNAseq_C21: shGLP etoh replicate 3


title: Nalm6_RNAseq_C23: shHP1g etoh replicate 3


title: Nalm6_RNAseq_C19: shG9a etoh replicate 3


title: Nalm6_RNAseq_C22: shGLP dex replicate 3


title: Nalm6_RNAseq_C20: shG9a dex replicate 3


title: Nalm6_RNAseq_C17: shNS etoh replicate 3


title: Nalm6_RNAseq_C18: shNS dex replicate 3


title: Nalm6_RNAseq_C16: shHP1g dex replicate 2


title: Nalm6_RNAseq_C15: shHP1g etoh replicate 2


title: Nalm6_RNAseq_C13: shGLP etoh replicate 2


title: Nalm6_RNAseq_C14: shGLP dex replicate 2


title: U3118MG cells transduced with shNT

city: Uppsala

first: Lene

last: Uhrbom

address: Dag Hammarskjölds väg 20

department: Immunology, Genetics and Pathology

institute: Uppsala University

description: Gene expression data from glioblastoma stem-like cells U3118MG cells transduced with shNT

hyb_protocol: GeneChip® ST Arrays (GeneChip® Human Transcriptome Array 2.0) were hybridized for 16 hours in a 45°C incubator, rotated at 60 rpm. According to the GeneChip® Expression Wash, Stain and Scan Manual (PN 702731 Rev. 3, Affymetrix Inc., Santa Clara, CA) the arrays were washed and stained using the Fluidics Station 450.

scan_protocol: The arrays were scanned using the GeneChip® Scanner 3000 7G.

data_processing: The raw data was normalized in R and the R-library Oligo using the robust multi-array average (RMA) function.

source_name: Primary human GBM

label_protocol: 250 nanograms of total RNA from each sample were used to generate amplified and biotinylated sense-strand cDNA from the entire expressed genome according to the GeneChip® WT PLUS Reagent Kit User Manual (P/N 703174 Rev 1 Affymetrix Inc., Santa Clara, CA).

growth_protocol: The cells were cultured in DMEM/F12 Glutamax (Gibco) and Neurobasal medium (Gibco) mixed 1:1 with addition of 1% B27 (Invitrogen), 0.5% N2 (Invitrogen), 1% Penicillin/Streptomycin (Sigma), 10 ng/ml each of EGF and FGF2 (Peprotech) on poly-ornithine/laminin-coated dishes as adherent cells.

extract_protocol: Total mRNA was extracted using the QIAGEN RNeasy kit (QIAGEN)

treatment_protocol: The cells were transduced with short hairpin RNA targeting LGR5 mRNA (shLGR5) or non-target RNA (shNT) as control.

value: primary glioblastoma

value: Glioblastoma stem-like cells

tag: lentiviral vector

value: shNT


title: Nalm6_RNAseq_C10: shNS dex replicate 2


title: Nalm6_RNAseq_C09: shNS etoh replicate 2


title: Nalm6_RNAseq_C11: shG9a etoh replicate 2


title: U3117MG cells transduced with shLGR5

description: Gene expression data from glioblastoma stem-like cells U3117MG cells transduced with shLGR5


title: U3060MG cells transduced with oeLGR5

description:
U3060MG_oeLGR5
Gene expression data from glioblastoma stem-like cells U3060MG cells transduced with oeLGR5.

extract_protocol: Total mRNA was extracted using the QIAGEN RNeasy kit (QIAGEN).

treatment_protocol: The cells were transduced with lentiviral vectors containing LGR5 cDNA (oeLGR5) or control (oeCTL).

tag: patient-derived cell line


title: U3020MG cells transduced with oeLGR5

description:
U3020MG_oeLGR5
Gene expression data from glioblastoma stem-like cells U3020MG cells transduced with oeLGR5.


title: U3060MG cells transduced with oeCTL

description:
U3060MG_oeCTL
Gene expression data from glioblastoma stem-like cells U3060MG cells transduced with oeCTL.

value: oeCTL


title: U3082MG cells transduced with shNT

description: Gene expression data from glioblastoma stem-like cells U3082MG cells transduced with shNT


title: U3117MG cells transduced with shNT

description: Gene expression data from glioblastoma stem-like cells U3117MG cells transduced with shNT


title: Nalm6_RNAseq_C06: shGLP dex replicate 1


title: U3082MG cells transduced with shLGR5

description: Gene expression data from glioblastoma stem-like cells U3082MG cells transduced with shLGR5


title: Nalm6_RNAseq_C05: shGLP etoh replicate 1


title: Nalm6_RNAseq_C07: shHP1g etoh replicate 1


title: Nalm6_RNAseq_C02: shNS dex replicate 1


title: U3020MG cells transduced with oeCTL

description:
U3020MG_oeCTL
Gene expression data from glioblastoma stem-like cells U3020MG cells transduced with oeCTL.


title: Nalm6_RNAseq_C01: shNS etoh replicate 1


title: Nalm6_RNAseq_C03: shG9a etoh replicate 1


title: Nalm6_RNAseq_C04: shG9a dex replicate 1


title: V1

city: Nijmegen

first: Klaas

last: Mulder

address: Geert Grooteplein 28

institute: RIMLS

description: Control sample, DMSO and 1%BSA in 4 mM HCL

data_processing:
fastq files were aligned to hg38, sorted and converted to bam files using STAR
data was filtered using the following specifications: select only reads for which at least 16bp match the reference genome and 5% of the read can be a mismatch
STAR generated bam files were used in DEXseq to produce the count tables.
DEXseq processed tables are included as processed data files, reporting exon usage per sample
Genome_build: hg38 (p10)
Supplementary_files_format_and_content: txt files containing exon usage per sample based on Gencode basic annotation (V27)

source_name: Foreskin keratinocytes

growth_protocol: Primary human foreskin keratinocytes were cultured on keratinocyte serum free medium (supplemented with 0,2 ng/mL EGF and 30 ug/mL BPE) in a T175 flask (6*10^6) prior to induction of differentiation

extract_protocol:
RNA isolation using Zymo Microprep RNA extraction kit (R1051)
Libraries were prepared according to the standard KAPA RNA Hyper Prep Kit with RiboErase KR1351

treatment_protocol: Differentiation was induced using a combination of 10 μM AG1478 (Calbiochem), 200 ng/mL human recombinant BMP 2/7 (R&D systems) which was added to the medium for 48 hours.

value: Foreskin keratinocytes

tag: days of culture


title: V3

value: Control sample, DMSO and 1%BSA in 4 mM HCL


title: Nalm6_RNAseq_C12: shG9a dex replicate 2


title: V2


title: AB2

description: Differentiation induced using using a combination of 10 μM AG1478 (Calbiochem), 200 ng/mL human recombinant BMP 2/7 (R&D systems) which was added to the medium for 48 hours.


title: AB1

value: 10 μM AG1478 (Calbiochem), 200 ng/mL human recombinant BMP 2/7 (R&D systems)


title: AB3


title: Nalm6_RNAseq_C08: shHP1g dex replicate 1


title: siSRSF1_3

source_name: SRSF1 silenced sample (79% KD efficiency)

growth_protocol: Primary human foreskin keratinocytes were cultured on keratinocyte serum free medium (supplemented with 0,2 ng/mL EGF and 30 ug/mL BPE) in a T175 flask (6*10^6) prior to nucleofection.

treatment_protocol: Cells were transfected using program FF113 on the 4D amaxa nucleofection system with scrambled siRNAs or siRNAs targeting SRSF1 or ZMAT2 whereafter the cells were cultured for 5 days.

tag: time

value: 5 days of culture

value: silenced for SRSF1


title: siZMAT2_2

source_name: ZMAT2 silenced sample (70% KD efficiency)

value: silenced for ZMAT2


title: U3118MG cells transduced with shLGR5

description: Gene expression data from glioblastoma stem-like cells U3118MG cells transduced with shLGR5


title: siSRSF1_2


title: siControl_3

source_name: Control sample, scramble siRNAs

value: control


title: siSRSF1_1


title: siZMAT2_3


title: siControl_2


title: siControl_1


title: CCRF-CEM_shLuc_H3K27m3

city: Boston

first: Ingrid

middle: M

last: Aries

state: MA

address: 1 Blackfan circle

department: Hematology/Oncology

institute: Boston Children's Hospital

data_processing:
Basecalls performed using bcl2fastq version 2.18
ChIP-seq reads were aligned to the reference genome (hg19) using BWA (version 0.7.13) with default parameters
Duplicated reads were filtered out with Picard (https://broadinstitute.github.io/picard/).  We also removed the reads with less than 20 bases of mapping quality from the alignment.
Chromatin immunoprecipitation peaks for H3K27me3 were called by Homer using default parameters requiring putative peak to have 3-fold more normalized tags in the ChIP experiment than the input and a cumulative poisson p-value threshold of 0.001. Putative peaks that were identified in regions of genomic duplication or repeat elements were filtered out
Genome_build: hg19
Supplementary_files_format_and_content: bigwig file were generated by makeUCSCfile, a component program in Homer

source_name: CCRF-CEM cell lines

extract_protocol:
Lysates were clarified from sonication which was performed to fragment chromatin to 200-700 bp size range using a Covaris E220 Focused-ultrasonicator. Immunoprecipitation was then performed on 5 million cells with H3K27me3 antibody
Libraries were prepared according to Illumina's instructions. Briefly, DNA was end-repaired using End-It DNA End-Repair Kit (Epicenter Cat. No. ER0720) and ‘A’ Base was added to the 3’ End of the DNA fragments. After Ligation of Adapters to the Ends of the DNA Fragments, adapter-modified DNA fragments were enriched by PCR.  SPRI bead size selection was used to remove remaining primers and select a size-range of templates. The Libraries were sequenced with the Illumina NextSeq 500 platfom following the manufacturer's protocols.

treatment_protocol: CCRF-CEM cells and CCRF-CEM cells transduced with shRNAs targeting control (Luciferase) or EZH2 were cross-linked using formaldehyde

value: CCRF-CEM Human T-cell lymphoblastic cell line

tag: transduction

value: shRNAs targeting control (Luciferase)

tag: antibody

value: anti-H3K27me3 antibody (Active Motif Cat #39155)


title: CCRF-CEM_shEZH2_H3K27me3

value: shRNAs targeting EZH2


title: CCRF-CEM_WCE


title: CCRF-CEM_shLUC_WCE


title: CCRF-CEM_shEZH2_WCE


title: cMOP 2/3

source_name: Common monocyte progenitor

extract_protocol: DNA was extracted using QIAamp DNA micro kit from Qiagen.

value: Naive

value: Bone marrow

tag: sorting strategy


title: siZMAT2_1


title: CCRF-CEM_H3K27me3


title: e15_5_9_GCTACGCT-TAGATCGC_0

city: Seattle

first: Raghav

last: Chawla

state: WA

address: 3720 15th Ave NE

department: Department of Genome Sciences

institute: University of Washington

data_processing:
Reads were aligned to the mouse reference genome build mm10 with TopHat (v2.0.13), which was provided with gene annotations from GENCODE (vM2).
Gene expression profiles for each cell were computed using Cufflinks (2.2.0).
Genome_build: mm10
Supplementary_files_format_and_content: The tarball includes gene and isoform FPKM tables, as well as samples annotations and gene attributes tables from the Cufflinks output.

extract_protocol:
Single-cell suspensions were prepared from pancreata of Neurogenin 3-eGFP mouse embryos sacrificed at different days of embryonic development. Single eGFP-positive cells were FACS-sorted into 96-well plates, and single-cell cDNA was prepared using the SMART-seq protocol.
Single-cell sequencing libraries were generated using the Nextera XT DNA library preparation kit.

value: Single-cell from pancreata of Neurogenin 3-eGFP mouse embryo

tag: developmental stage


title: e15_5_88_TCCTGAGC-CTAAGCCT_0

source_name: pancreata of Neurogenin 3-eGFP mouse embryo


title: e15_5_93_GCTACGCT-CTAAGCCT_0


title: e15_5_86_CGTACTAG-CTAAGCCT_0


title: e15_5_89_GGACTCCT-CTAAGCCT_0


title: e15_5_92_CAGAGAGG-CTAAGCCT_0


title: e15_5_95_AAGAGGCA-CTAAGCCT_0


title: e15_5_96_GTAGAGGA-CTAAGCCT_0


title: e15_5_83_AAGAGGCA-AAGGAGTA_0


title: e15_5_90_TAGGCATG-CTAAGCCT_0


title: e15_5_82_CGAGGCTG-AAGGAGTA_0


title: e15_5_84_GTAGAGGA-AAGGAGTA_0


title: e15_5_91_CTCTCTAC-CTAAGCCT_0


title: e15_5_81_GCTACGCT-AAGGAGTA_0


title: e15_5_80_CAGAGAGG-AAGGAGTA_0


title: e15_5_7_CTCTCTAC-TAGATCGC_0


title: e15_5_79_CTCTCTAC-AAGGAGTA_0


title: e15_5_77_GGACTCCT-AAGGAGTA_0


title: e15_5_78_TAGGCATG-AAGGAGTA_0


title: e15_5_94_CGAGGCTG-CTAAGCCT_0


title: e15_5_75_AGGCAGAA-AAGGAGTA_0


title: e15_5_8_CAGAGAGG-TAGATCGC_0


title: e15_5_74_CGTACTAG-AAGGAGTA_0


title: e15_5_87_AGGCAGAA-CTAAGCCT_0


title: e15_5_73_TAAGGCGA-AAGGAGTA_0


title: e15_5_72_GTAGAGGA-ACTGCATA_0


title: e15_5_71_AAGAGGCA-ACTGCATA_0


title: e15_5_70_CGAGGCTG-ACTGCATA_0


title: e15_5_67_CTCTCTAC-ACTGCATA_0


title: e15_5_62_CGTACTAG-ACTGCATA_0


title: e15_5_68_CAGAGAGG-ACTGCATA_0


title: e15_5_60_GTAGAGGA-GTAAGGAG_0


title: e15_5_63_AGGCAGAA-ACTGCATA_0


title: e15_5_6_TAGGCATG-TAGATCGC_0


title: e15_5_61_TAAGGCGA-ACTGCATA_0


title: e15_5_58_CGAGGCTG-GTAAGGAG_0


title: e15_5_5_GGACTCCT-TAGATCGC_0


title: e15_5_57_GCTACGCT-GTAAGGAG_0


title: e15_5_76_TCCTGAGC-AAGGAGTA_0


title: e15_5_52_TCCTGAGC-GTAAGGAG_0


title: e15_5_55_CTCTCTAC-GTAAGGAG_0


title: e15_5_51_AGGCAGAA-GTAAGGAG_0


title: e15_5_59_AAGAGGCA-GTAAGGAG_0


title: e15_5_69_GCTACGCT-ACTGCATA_0


title: e15_5_54_TAGGCATG-GTAAGGAG_0


title: e15_5_66_TAGGCATG-ACTGCATA_0


title: e15_5_4_TCCTGAGC-TAGATCGC_0


title: e15_5_65_GGACTCCT-ACTGCATA_0


title: e15_5_64_TCCTGAGC-ACTGCATA_0


title: e15_5_49_TAAGGCGA-GTAAGGAG_0


title: e15_5_47_AAGAGGCA-AGAGTAGA_0


title: e15_5_50_CGTACTAG-GTAAGGAG_0


title: e15_5_46_CGAGGCTG-AGAGTAGA_0


title: e15_5_45_GCTACGCT-AGAGTAGA_0


title: e15_5_48_GTAGAGGA-AGAGTAGA_0


title: e15_5_44_CAGAGAGG-AGAGTAGA_0


title: e15_5_56_CAGAGAGG-GTAAGGAG_0


title: e15_5_40_TCCTGAGC-AGAGTAGA_0


title: e15_5_43_CTCTCTAC-AGAGTAGA_0


title: e15_5_53_GGACTCCT-GTAAGGAG_0


title: e15_5_41_GGACTCCT-AGAGTAGA_0


title: e15_5_42_TAGGCATG-AGAGTAGA_0


title: e15_5_39_AGGCAGAA-AGAGTAGA_0


title: e15_5_3_AGGCAGAA-TAGATCGC_0


title: e15_5_35_AAGAGGCA-TATCCTCT_0


title: e15_5_34_CGAGGCTG-TATCCTCT_0


title: e15_5_38_CGTACTAG-AGAGTAGA_0


title: e15_5_37_TAAGGCGA-AGAGTAGA_0


title: e15_5_36_GTAGAGGA-TATCCTCT_0


title: e15_5_31_CTCTCTAC-TATCCTCT_0


title: e15_5_29_GGACTCCT-TATCCTCT_0


title: e15_5_28_TCCTGAGC-TATCCTCT_0


title: e15_5_22_CGAGGCTG-CTCTCTAT_0


title: e15_5_26_CGTACTAG-TATCCTCT_0


title: e15_5_27_AGGCAGAA-TATCCTCT_0


title: e15_5_25_TAAGGCGA-TATCCTCT_0


title: e15_5_33_GCTACGCT-TATCCTCT_0


title: e15_5_21_GCTACGCT-CTCTCTAT_0


title: e15_5_24_GTAGAGGA-CTCTCTAT_0


title: e15_5_20_CAGAGAGG-CTCTCTAT_0


title: e15_5_1_TAAGGCGA-TAGATCGC_0


title: e15_5_23_AAGAGGCA-CTCTCTAT_0


title: e15_5_19_CTCTCTAC-CTCTCTAT_0


title: e15_5_18_TAGGCATG-CTCTCTAT_0


title: e15_5_32_CAGAGAGG-TATCCTCT_0


title: e15_5_16_TCCTGAGC-CTCTCTAT_0


title: e15_5_15_AGGCAGAA-CTCTCTAT_0


title: e15_5_12_GTAGAGGA-TAGATCGC_0


title: e15_5_30_TAGGCATG-TATCCTCT_0


title: e15_5_14_CGTACTAG-CTCTCTAT_0


title: e15_5_13_TAAGGCGA-CTCTCTAT_0


title: e15_5_2_CGTACTAG-TAGATCGC_0


title: e15_5_17_GGACTCCT-CTCTCTAT_0


title: e15_5_10_CGAGGCTG-TAGATCGC_0


title: e14_5_9_GCTACGCT-TAGATCGC_0


title: e15_5_11_AAGAGGCA-TAGATCGC_0


title: e14_5_95_AAGAGGCA-CTAAGCCT_0


title: e14_5_92_CAGAGAGG-CTAAGCCT_0


title: e14_5_93_GCTACGCT-CTAAGCCT_0


title: e14_5_90_TAGGCATG-CTAAGCCT_0


title: e14_5_89_GGACTCCT-CTAAGCCT_0


title: e14_5_94_CGAGGCTG-CTAAGCCT_0


title: e14_5_91_CTCTCTAC-CTAAGCCT_0


title: e14_5_8_CAGAGAGG-TAGATCGC_0


title: e14_5_85_TAAGGCGA-CTAAGCCT_0


title: e14_5_87_AGGCAGAA-CTAAGCCT_0


title: e14_5_83_AAGAGGCA-AAGGAGTA_0


title: e14_5_86_CGTACTAG-CTAAGCCT_0


title: e14_5_88_TCCTGAGC-CTAAGCCT_0


title: e14_5_84_GTAGAGGA-AAGGAGTA_0


title: e14_5_81_GCTACGCT-AAGGAGTA_0


title: e14_5_80_CAGAGAGG-AAGGAGTA_0


title: e14_5_96_GTAGAGGA-CTAAGCCT_0


title: e14_5_7_CTCTCTAC-TAGATCGC_0


title: e14_5_79_CTCTCTAC-AAGGAGTA_0


title: e14_5_74_CGTACTAG-AAGGAGTA_0


title: e14_5_76_TCCTGAGC-AAGGAGTA_0


title: e14_5_73_TAAGGCGA-AAGGAGTA_0


title: e14_5_78_TAGGCATG-AAGGAGTA_0


title: e14_5_77_GGACTCCT-AAGGAGTA_0


title: e14_5_70_CGAGGCTG-ACTGCATA_0


title: e14_5_71_AAGAGGCA-ACTGCATA_0


title: e14_5_75_AGGCAGAA-AAGGAGTA_0


title: e14_5_82_CGAGGCTG-AAGGAGTA_0


title: e14_5_6_TAGGCATG-TAGATCGC_0


title: e14_5_68_CAGAGAGG-ACTGCATA_0


title: e14_5_62_CGTACTAG-ACTGCATA_0


title: e14_5_69_GCTACGCT-ACTGCATA_0


title: e14_5_64_TCCTGAGC-ACTGCATA_0


title: e14_5_61_TAAGGCGA-ACTGCATA_0


title: e14_5_63_AGGCAGAA-ACTGCATA_0


title: e14_5_66_TAGGCATG-ACTGCATA_0


title: e14_5_65_GGACTCCT-ACTGCATA_0


title: e14_5_5_GGACTCCT-TAGATCGC_0


title: e14_5_58_CGAGGCTG-GTAAGGAG_0


title: e14_5_67_CTCTCTAC-ACTGCATA_0


title: e14_5_56_CAGAGAGG-GTAAGGAG_0


title: e14_5_59_AAGAGGCA-GTAAGGAG_0


title: e14_5_54_TAGGCATG-GTAAGGAG_0


title: e14_5_55_CTCTCTAC-GTAAGGAG_0


title: e14_5_53_GGACTCCT-GTAAGGAG_0


title: e14_5_4_TCCTGAGC-TAGATCGC_0


title: e14_5_50_CGTACTAG-GTAAGGAG_0


title: e14_5_51_AGGCAGAA-GTAAGGAG_0


title: e14_5_52_TCCTGAGC-GTAAGGAG_0


title: e14_5_48_GTAGAGGA-AGAGTAGA_0


title: e14_5_45_GCTACGCT-AGAGTAGA_0


title: e14_5_46_CGAGGCTG-AGAGTAGA_0


title: e14_5_60_GTAGAGGA-GTAAGGAG_0


title: e14_5_49_TAAGGCGA-GTAAGGAG_0


title: e14_5_47_AAGAGGCA-AGAGTAGA_0


title: e14_5_57_GCTACGCT-GTAAGGAG_0


title: e14_5_3_AGGCAGAA-TAGATCGC_0


title: e14_5_38_CGTACTAG-AGAGTAGA_0


title: e14_5_43_CTCTCTAC-AGAGTAGA_0


title: e14_5_39_AGGCAGAA-AGAGTAGA_0


title: e14_5_40_TCCTGAGC-AGAGTAGA_0


title: e14_5_36_GTAGAGGA-TATCCTCT_0


title: e14_5_37_TAAGGCGA-AGAGTAGA_0


title: e14_5_41_GGACTCCT-AGAGTAGA_0


title: e14_5_34_CGAGGCTG-TATCCTCT_0


title: e14_5_32_CAGAGAGG-TATCCTCT_0


title: e14_5_42_TAGGCATG-AGAGTAGA_0


title: e14_5_29_GGACTCCT-TATCCTCT_0


title: e14_5_2_CGTACTAG-TAGATCGC_0


title: e14_5_30_TAGGCATG-TATCCTCT_0


title: e14_5_28_TCCTGAGC-TATCCTCT_0


title: e14_5_27_AGGCAGAA-TATCCTCT_0


title: e14_5_44_CAGAGAGG-AGAGTAGA_0


title: e14_5_26_CGTACTAG-TATCCTCT_0


title: e14_5_24_GTAGAGGA-CTCTCTAT_0


title: e14_5_21_GCTACGCT-CTCTCTAT_0


title: e14_5_20_CAGAGAGG-CTCTCTAT_0


title: e14_5_23_AAGAGGCA-CTCTCTAT_0


title: e14_5_22_CGAGGCTG-CTCTCTAT_0


title: e14_5_19_CTCTCTAC-CTCTCTAT_0


title: e14_5_18_TAGGCATG-CTCTCTAT_0


title: e14_5_1_TAAGGCGA-TAGATCGC_0


title: e14_5_31_CTCTCTAC-TATCCTCT_0


title: e14_5_35_AAGAGGCA-TATCCTCT_0


title: e14_5_33_GCTACGCT-TATCCTCT_0


title: e14_5_16_TCCTGAGC-CTCTCTAT_0


title: e14_5_12_GTAGAGGA-TAGATCGC_0


title: e14_5_14_CGTACTAG-CTCTCTAT_0


title: e14_5_13_TAAGGCGA-CTCTCTAT_0


title: e14_5_10_CGAGGCTG-TAGATCGC_0


title: e14_5_11_AAGAGGCA-TAGATCGC_0


title: e13_5_96_GTAGAGGA-CTAAGCCT_0


title: e14_5_15_AGGCAGAA-CTCTCTAT_0


title: e13_5_94_CGAGGCTG-CTAAGCCT_0


title: e13_5_93_GCTACGCT-CTAAGCCT_0


title: e13_5_92_CAGAGAGG-CTAAGCCT_0


title: e13_5_95_AAGAGGCA-CTAAGCCT_0


title: e13_5_91_CTCTCTAC-CTAAGCCT_0


title: e14_5_25_TAAGGCGA-TATCCTCT_0


title: e13_5_8_CAGAGAGG-TAGATCGC_0


title: e13_5_89_GGACTCCT-CTAAGCCT_0


title: e13_5_88_TCCTGAGC-CTAAGCCT_0


title: e13_5_87_AGGCAGAA-CTAAGCCT_0


title: e13_5_84_GTAGAGGA-AAGGAGTA_0


title: e13_5_83_AAGAGGCA-AAGGAGTA_0


title: e13_5_85_TAAGGCGA-CTAAGCCT_0


title: e13_5_81_GCTACGCT-AAGGAGTA_0


title: e13_5_7_CTCTCTAC-TAGATCGC_0


title: e14_5_17_GGACTCCT-CTCTCTAT_0


title: e13_5_82_CGAGGCTG-AAGGAGTA_0


title: e13_5_80_CAGAGAGG-AAGGAGTA_0


title: e13_5_9_GCTACGCT-TAGATCGC_0


title: e13_5_79_CTCTCTAC-AAGGAGTA_0


title: e13_5_78_TAGGCATG-AAGGAGTA_0


title: e13_5_74_CGTACTAG-AAGGAGTA_0


title: e13_5_76_TCCTGAGC-AAGGAGTA_0


title: e13_5_73_TAAGGCGA-AAGGAGTA_0


title: e13_5_72_GTAGAGGA-ACTGCATA_0


title: e13_5_70_CGAGGCTG-ACTGCATA_0


title: e13_5_6_TAGGCATG-TAGATCGC_0


title: e13_5_71_AAGAGGCA-ACTGCATA_0


title: e13_5_75_AGGCAGAA-AAGGAGTA_0


title: e13_5_77_GGACTCCT-AAGGAGTA_0


title: e13_5_67_CTCTCTAC-ACTGCATA_0


title: e13_5_68_CAGAGAGG-ACTGCATA_0


title: e13_5_69_GCTACGCT-ACTGCATA_0


title: e13_5_66_TAGGCATG-ACTGCATA_0


title: e13_5_65_GGACTCCT-ACTGCATA_0


title: e13_5_63_AGGCAGAA-ACTGCATA_0


title: e13_5_86_CGTACTAG-CTAAGCCT_0


title: e13_5_64_TCCTGAGC-ACTGCATA_0


title: e13_5_62_CGTACTAG-ACTGCATA_0


title: e13_5_61_TAAGGCGA-ACTGCATA_0


title: e13_5_5_GGACTCCT-TAGATCGC_0


title: e13_5_60_GTAGAGGA-GTAAGGAG_0


title: e13_5_59_AAGAGGCA-GTAAGGAG_0


title: e13_5_58_CGAGGCTG-GTAAGGAG_0


title: e13_5_56_CAGAGAGG-GTAAGGAG_0


title: e13_5_57_GCTACGCT-GTAAGGAG_0


title: e13_5_55_CTCTCTAC-GTAAGGAG_0


title: e13_5_54_TAGGCATG-GTAAGGAG_0


title: e13_5_53_GGACTCCT-GTAAGGAG_0


title: e13_5_48_GTAGAGGA-AGAGTAGA_0


title: e13_5_52_TCCTGAGC-GTAAGGAG_0


title: e13_5_51_AGGCAGAA-GTAAGGAG_0


title: e13_5_50_CGTACTAG-GTAAGGAG_0


title: e13_5_4_TCCTGAGC-TAGATCGC_0


title: e13_5_45_GCTACGCT-AGAGTAGA_0


title: e13_5_46_CGAGGCTG-AGAGTAGA_0


title: e13_5_44_CAGAGAGG-AGAGTAGA_0


title: e13_5_47_AAGAGGCA-AGAGTAGA_0


title: e13_5_42_TAGGCATG-AGAGTAGA_0


title: e13_5_39_AGGCAGAA-AGAGTAGA_0


title: e13_5_3_AGGCAGAA-TAGATCGC_0


title: e13_5_38_CGTACTAG-AGAGTAGA_0


title: e13_5_40_TCCTGAGC-AGAGTAGA_0


title: e13_5_41_GGACTCCT-AGAGTAGA_0


title: e13_5_37_TAAGGCGA-AGAGTAGA_0


title: e13_5_34_CGAGGCTG-TATCCTCT_0


title: e13_5_32_CAGAGAGG-TATCCTCT_0


title: e13_5_35_AAGAGGCA-TATCCTCT_0


title: e13_5_33_GCTACGCT-TATCCTCT_0


title: e13_5_2_CGTACTAG-TAGATCGC_0


title: e13_5_31_CTCTCTAC-TATCCTCT_0


title: e13_5_30_TAGGCATG-TATCCTCT_0


title: e13_5_29_GGACTCCT-TATCCTCT_0


title: e13_5_28_TCCTGAGC-TATCCTCT_0


title: e13_5_27_AGGCAGAA-TATCCTCT_0


title: e13_5_26_CGTACTAG-TATCCTCT_0


title: e13_5_25_TAAGGCGA-TATCCTCT_0


title: e13_5_43_CTCTCTAC-AGAGTAGA_0


title: e13_5_23_AAGAGGCA-CTCTCTAT_0


title: e13_5_24_GTAGAGGA-CTCTCTAT_0


title: e13_5_1_TAAGGCGA-TAGATCGC_0


title: e13_5_22_CGAGGCTG-CTCTCTAT_0


title: e13_5_20_CAGAGAGG-CTCTCTAT_0


title: e13_5_17_GGACTCCT-CTCTCTAT_0


title: e13_5_16_TCCTGAGC-CTCTCTAT_0


title: e13_5_49_TAAGGCGA-GTAAGGAG_0


title: e13_5_19_CTCTCTAC-CTCTCTAT_0


title: e13_5_15_AGGCAGAA-CTCTCTAT_0


title: e13_5_18_TAGGCATG-CTCTCTAT_0


title: e13_5_14_CGTACTAG-CTCTCTAT_0


title: e13_5_13_TAAGGCGA-CTCTCTAT_0


title: Sample_E14_5_TCCTGAGC-TATCCTCT_0

description: first_run/Sample_E14_5_TCCTGAGC-TATCCTCT_0


title: e13_5_10_CGAGGCTG-TAGATCGC_0


title: e13_5_12_GTAGAGGA-TAGATCGC_0


title: e13_5_11_AAGAGGCA-TAGATCGC_0


title: Sample_E14_5_TCCTGAGC-CTCTCTAT_0

description: first_run/Sample_E14_5_TCCTGAGC-CTCTCTAT_0


title: Sample_E14_5_TCCTGAGC-ACTGCATA_0

description: first_run/Sample_E14_5_TCCTGAGC-ACTGCATA_0


title: Sample_E14_5_TCCTGAGC-AGAGTAGA_0

description: first_run/Sample_E14_5_TCCTGAGC-AGAGTAGA_0


title: Sample_E14_5_TCCTGAGC-CTAAGCCT_0

description: first_run/Sample_E14_5_TCCTGAGC-CTAAGCCT_0


title: Sample_E14_5_TCCTGAGC-AAGGAGTA_0

description: first_run/Sample_E14_5_TCCTGAGC-AAGGAGTA_0


title: Sample_E14_5_TAGGCATG-TATCCTCT_0

description: first_run/Sample_E14_5_TAGGCATG-TATCCTCT_0


title: Sample_E14_5_TAGGCATG-TAGATCGC_0

description: first_run/Sample_E14_5_TAGGCATG-TAGATCGC_0


title: Sample_E14_5_TAGGCATG-GTAAGGAG_0

description: first_run/Sample_E14_5_TAGGCATG-GTAAGGAG_0


title: Sample_E14_5_TAGGCATG-CTCTCTAT_0

description: first_run/Sample_E14_5_TAGGCATG-CTCTCTAT_0


title: Sample_E14_5_TAGGCATG-CTAAGCCT_0

description: first_run/Sample_E14_5_TAGGCATG-CTAAGCCT_0


title: Sample_E14_5_TAGGCATG-ACTGCATA_0

description: first_run/Sample_E14_5_TAGGCATG-ACTGCATA_0


title: Sample_E14_5_TAAGGCGA-TAGATCGC_0

description: first_run/Sample_E14_5_TAAGGCGA-TAGATCGC_0


title: Sample_E14_5_TAGGCATG-AGAGTAGA_0

description: first_run/Sample_E14_5_TAGGCATG-AGAGTAGA_0


title: Sample_E14_5_TAAGGCGA-CTCTCTAT_0

description: first_run/Sample_E14_5_TAAGGCGA-CTCTCTAT_0


title: Sample_E14_5_TAAGGCGA-TATCCTCT_0

description: first_run/Sample_E14_5_TAAGGCGA-TATCCTCT_0


title: Sample_E14_5_TAAGGCGA-CTAAGCCT_0

description: first_run/Sample_E14_5_TAAGGCGA-CTAAGCCT_0


title: Sample_E14_5_TAAGGCGA-AGAGTAGA_0

description: first_run/Sample_E14_5_TAAGGCGA-AGAGTAGA_0


title: Sample_E14_5_GTAGAGGA-TAGATCGC_0

description: first_run/Sample_E14_5_GTAGAGGA-TAGATCGC_0


title: Sample_E14_5_GTAGAGGA-GTAAGGAG_0

description: first_run/Sample_E14_5_GTAGAGGA-GTAAGGAG_0


title: Sample_E14_5_TAAGGCGA-AAGGAGTA_0

description: first_run/Sample_E14_5_TAAGGCGA-AAGGAGTA_0


title: Sample_E14_5_GTAGAGGA-CTCTCTAT_0

description: first_run/Sample_E14_5_GTAGAGGA-CTCTCTAT_0


title: Sample_E14_5_GTAGAGGA-AGAGTAGA_0

description: first_run/Sample_E14_5_GTAGAGGA-AGAGTAGA_0


title: Sample_E14_5_TCCTGAGC-GTAAGGAG_0

description: first_run/Sample_E14_5_TCCTGAGC-GTAAGGAG_0


title: Sample_E14_5_GTAGAGGA-CTAAGCCT_0

description: first_run/Sample_E14_5_GTAGAGGA-CTAAGCCT_0


title: Sample_E14_5_TCCTGAGC-TAGATCGC_0

description: first_run/Sample_E14_5_TCCTGAGC-TAGATCGC_0


title: Sample_E14_5_GTAGAGGA-ACTGCATA_0

description: first_run/Sample_E14_5_GTAGAGGA-ACTGCATA_0


title: Sample_E14_5_GGACTCCT-CTCTCTAT_0

description: first_run/Sample_E14_5_GGACTCCT-CTCTCTAT_0


title: Sample_E14_5_GGACTCCT-TAGATCGC_0

description: first_run/Sample_E14_5_GGACTCCT-TAGATCGC_0


title: Sample_E14_5_GGACTCCT-TATCCTCT_0

description: first_run/Sample_E14_5_GGACTCCT-TATCCTCT_0


title: Sample_E14_5_GTAGAGGA-AAGGAGTA_0

description: first_run/Sample_E14_5_GTAGAGGA-AAGGAGTA_0


title: Sample_E14_5_GGACTCCT-GTAAGGAG_0

description: first_run/Sample_E14_5_GGACTCCT-GTAAGGAG_0


title: Sample_E14_5_GGACTCCT-AGAGTAGA_0

description: first_run/Sample_E14_5_GGACTCCT-AGAGTAGA_0


title: Sample_E14_5_GGACTCCT-CTAAGCCT_0

description: first_run/Sample_E14_5_GGACTCCT-CTAAGCCT_0


title: Sample_E14_5_GGACTCCT-AAGGAGTA_0

description: first_run/Sample_E14_5_GGACTCCT-AAGGAGTA_0


title: Sample_E14_5_TAAGGCGA-ACTGCATA_0

description: first_run/Sample_E14_5_TAAGGCGA-ACTGCATA_0


title: Sample_E14_5_GCTACGCT-TAGATCGC_0

description: first_run/Sample_E14_5_GCTACGCT-TAGATCGC_0


title: Sample_E14_5_GCTACGCT-TATCCTCT_0

description: first_run/Sample_E14_5_GCTACGCT-TATCCTCT_0


title: Sample_E14_5_GCTACGCT-CTCTCTAT_0

description: first_run/Sample_E14_5_GCTACGCT-CTCTCTAT_0


title: Sample_E14_5_TAAGGCGA-GTAAGGAG_0

description: first_run/Sample_E14_5_TAAGGCGA-GTAAGGAG_0


title: Sample_E14_5_GCTACGCT-GTAAGGAG_0

description: first_run/Sample_E14_5_GCTACGCT-GTAAGGAG_0


title: Sample_E14_5_GTAGAGGA-TATCCTCT_0

description: first_run/Sample_E14_5_GTAGAGGA-TATCCTCT_0


title: Sample_E14_5_GCTACGCT-AAGGAGTA_0

description: first_run/Sample_E14_5_GCTACGCT-AAGGAGTA_0


title: Sample_E14_5_GCTACGCT-ACTGCATA_0

description: first_run/Sample_E14_5_GCTACGCT-ACTGCATA_0


title: Sample_E14_5_CTCTCTAC-TATCCTCT_0

description: first_run/Sample_E14_5_CTCTCTAC-TATCCTCT_0


title: Sample_E14_5_CTCTCTAC-GTAAGGAG_0

description: first_run/Sample_E14_5_CTCTCTAC-GTAAGGAG_0


title: Sample_E14_5_CTCTCTAC-TAGATCGC_0

description: first_run/Sample_E14_5_CTCTCTAC-TAGATCGC_0


title: Sample_E14_5_CTCTCTAC-CTCTCTAT_0

description: first_run/Sample_E14_5_CTCTCTAC-CTCTCTAT_0


title: Sample_E14_5_CTCTCTAC-AGAGTAGA_0

description: first_run/Sample_E14_5_CTCTCTAC-AGAGTAGA_0


title: Sample_E14_5_CTCTCTAC-AAGGAGTA_0

description: first_run/Sample_E14_5_CTCTCTAC-AAGGAGTA_0


title: Sample_E14_5_CTCTCTAC-CTAAGCCT_0

description: first_run/Sample_E14_5_CTCTCTAC-CTAAGCCT_0


title: Sample_E14_5_GGACTCCT-ACTGCATA_0

description: first_run/Sample_E14_5_GGACTCCT-ACTGCATA_0


title: Sample_E14_5_CGTACTAG-TATCCTCT_0

description: first_run/Sample_E14_5_CGTACTAG-TATCCTCT_0


title: Sample_E14_5_CGTACTAG-AGAGTAGA_0

description: first_run/Sample_E14_5_CGTACTAG-AGAGTAGA_0


title: Sample_E14_5_CGTACTAG-CTAAGCCT_0

description: first_run/Sample_E14_5_CGTACTAG-CTAAGCCT_0


title: Sample_E14_5_CGTACTAG-CTCTCTAT_0

description: first_run/Sample_E14_5_CGTACTAG-CTCTCTAT_0


title: Sample_E14_5_CGTACTAG-TAGATCGC_0

description: first_run/Sample_E14_5_CGTACTAG-TAGATCGC_0


title: Sample_E14_5_CGTACTAG-ACTGCATA_0

description: first_run/Sample_E14_5_CGTACTAG-ACTGCATA_0


title: Sample_E14_5_CGTACTAG-AAGGAGTA_0

description: first_run/Sample_E14_5_CGTACTAG-AAGGAGTA_0


title: Sample_E14_5_CGTACTAG-GTAAGGAG_0

description: first_run/Sample_E14_5_CGTACTAG-GTAAGGAG_0


title: Sample_E14_5_GCTACGCT-CTAAGCCT_0

description: first_run/Sample_E14_5_GCTACGCT-CTAAGCCT_0


title: Sample_E14_5_CGAGGCTG-TATCCTCT_0

description: first_run/Sample_E14_5_CGAGGCTG-TATCCTCT_0


title: Sample_E14_5_GCTACGCT-AGAGTAGA_0

description: first_run/Sample_E14_5_GCTACGCT-AGAGTAGA_0


title: Sample_E14_5_CGAGGCTG-CTCTCTAT_0

description: first_run/Sample_E14_5_CGAGGCTG-CTCTCTAT_0


title: Sample_E14_5_CGAGGCTG-CTAAGCCT_0

description: first_run/Sample_E14_5_CGAGGCTG-CTAAGCCT_0


title: Sample_E14_5_CGAGGCTG-GTAAGGAG_0

description: first_run/Sample_E14_5_CGAGGCTG-GTAAGGAG_0


title: Sample_E14_5_CGAGGCTG-AGAGTAGA_0

description: first_run/Sample_E14_5_CGAGGCTG-AGAGTAGA_0


title: Sample_E14_5_CAGAGAGG-TATCCTCT_0

description: first_run/Sample_E14_5_CAGAGAGG-TATCCTCT_0


title: Sample_E14_5_CGAGGCTG-ACTGCATA_0

description: first_run/Sample_E14_5_CGAGGCTG-ACTGCATA_0


title: Sample_E14_5_CGAGGCTG-TAGATCGC_0

description: first_run/Sample_E14_5_CGAGGCTG-TAGATCGC_0


title: Sample_E14_5_CAGAGAGG-TAGATCGC_0

description: first_run/Sample_E14_5_CAGAGAGG-TAGATCGC_0


title: Sample_E14_5_CAGAGAGG-GTAAGGAG_0

description: first_run/Sample_E14_5_CAGAGAGG-GTAAGGAG_0


title: Sample_E14_5_CAGAGAGG-CTAAGCCT_0

description: first_run/Sample_E14_5_CAGAGAGG-CTAAGCCT_0


title: Sample_E14_5_CGAGGCTG-AAGGAGTA_0

description: first_run/Sample_E14_5_CGAGGCTG-AAGGAGTA_0


title: Sample_E14_5_CAGAGAGG-ACTGCATA_0

description: first_run/Sample_E14_5_CAGAGAGG-ACTGCATA_0


title: Sample_E14_5_CTCTCTAC-ACTGCATA_0

description: first_run/Sample_E14_5_CTCTCTAC-ACTGCATA_0


title: Sample_E14_5_CAGAGAGG-AGAGTAGA_0

description: first_run/Sample_E14_5_CAGAGAGG-AGAGTAGA_0


title: Sample_E14_5_AGGCAGAA-TATCCTCT_0

description: first_run/Sample_E14_5_AGGCAGAA-TATCCTCT_0


title: Sample_E14_5_CAGAGAGG-AAGGAGTA_0

description: first_run/Sample_E14_5_CAGAGAGG-AAGGAGTA_0


title: Sample_E14_5_AGGCAGAA-TAGATCGC_0

description: first_run/Sample_E14_5_AGGCAGAA-TAGATCGC_0


title: Sample_E14_5_AGGCAGAA-CTCTCTAT_0

description: first_run/Sample_E14_5_AGGCAGAA-CTCTCTAT_0


title: Sample_E14_5_AGGCAGAA-ACTGCATA_0

description: first_run/Sample_E14_5_AGGCAGAA-ACTGCATA_0


title: Sample_E14_5_AAGAGGCA-TATCCTCT_0

description: first_run/Sample_E14_5_AAGAGGCA-TATCCTCT_0


title: Sample_E14_5_AGGCAGAA-AAGGAGTA_0

description: first_run/Sample_E14_5_AGGCAGAA-AAGGAGTA_0


title: Sample_E14_5_AGGCAGAA-CTAAGCCT_0

description: first_run/Sample_E14_5_AGGCAGAA-CTAAGCCT_0


title: Sample_E14_5_AAGAGGCA-TAGATCGC_0

description: first_run/Sample_E14_5_AAGAGGCA-TAGATCGC_0


title: Sample_E14_5_AAGAGGCA-GTAAGGAG_0

description: first_run/Sample_E14_5_AAGAGGCA-GTAAGGAG_0


title: Sample_E14_5_AAGAGGCA-CTCTCTAT_0

description: first_run/Sample_E14_5_AAGAGGCA-CTCTCTAT_0


title: Sample_E14_5_AAGAGGCA-CTAAGCCT_0

description: first_run/Sample_E14_5_AAGAGGCA-CTAAGCCT_0


title: Sample_E14_5_AAGAGGCA-AGAGTAGA_0

description: first_run/Sample_E14_5_AAGAGGCA-AGAGTAGA_0


title: Sample_E14_5_AAGAGGCA-ACTGCATA_0

description: first_run/Sample_E14_5_AAGAGGCA-ACTGCATA_0


title: Sample_E14_5_CAGAGAGG-CTCTCTAT_0

description: first_run/Sample_E14_5_CAGAGAGG-CTCTCTAT_0


title: Sample_E14_5_AAGAGGCA-AAGGAGTA_0

description: first_run/Sample_E14_5_AAGAGGCA-AAGGAGTA_0


title: Sample_E12_5_TCCTGAGC-CTCTCTAT_0

description: first_run/Sample_E12_5_TCCTGAGC-CTCTCTAT_0


title: Sample_E12_5_TCCTGAGC-GTAAGGAG_0

description: first_run/Sample_E12_5_TCCTGAGC-GTAAGGAG_0


title: Sample_E12_5_TCCTGAGC-TATCCTCT_0

description: first_run/Sample_E12_5_TCCTGAGC-TATCCTCT_0


title: Sample_E12_5_TCCTGAGC-AGAGTAGA_0

description: first_run/Sample_E12_5_TCCTGAGC-AGAGTAGA_0


title: Sample_E12_5_TCCTGAGC-TAGATCGC_0

description: first_run/Sample_E12_5_TCCTGAGC-TAGATCGC_0


title: Sample_E12_5_TCCTGAGC-CTAAGCCT_0

description: first_run/Sample_E12_5_TCCTGAGC-CTAAGCCT_0


title: Sample_E14_5_AGGCAGAA-GTAAGGAG_0

description: first_run/Sample_E14_5_AGGCAGAA-GTAAGGAG_0


title: Sample_E12_5_TCCTGAGC-AAGGAGTA_0

description: first_run/Sample_E12_5_TCCTGAGC-AAGGAGTA_0


title: Sample_E12_5_TCCTGAGC-ACTGCATA_0

description: first_run/Sample_E12_5_TCCTGAGC-ACTGCATA_0


title: Sample_E14_5_AGGCAGAA-AGAGTAGA_0

description: first_run/Sample_E14_5_AGGCAGAA-AGAGTAGA_0


title: Sample_E12_5_TAGGCATG-TATCCTCT_0

description: first_run/Sample_E12_5_TAGGCATG-TATCCTCT_0


title: Sample_E12_5_TAGGCATG-CTAAGCCT_0

description: first_run/Sample_E12_5_TAGGCATG-CTAAGCCT_0


title: Sample_E12_5_TAGGCATG-AGAGTAGA_0

description: first_run/Sample_E12_5_TAGGCATG-AGAGTAGA_0


title: Sample_E12_5_TAAGGCGA-CTCTCTAT_0

description: first_run/Sample_E12_5_TAAGGCGA-CTCTCTAT_0


title: Sample_E12_5_TAGGCATG-CTCTCTAT_0

description: first_run/Sample_E12_5_TAGGCATG-CTCTCTAT_0


title: Sample_E12_5_TAGGCATG-GTAAGGAG_0

description: first_run/Sample_E12_5_TAGGCATG-GTAAGGAG_0


title: Sample_E12_5_TAAGGCGA-TATCCTCT_0

description: first_run/Sample_E12_5_TAAGGCGA-TATCCTCT_0


title: Sample_E12_5_TAGGCATG-AAGGAGTA_0

description: first_run/Sample_E12_5_TAGGCATG-AAGGAGTA_0


title: Sample_E12_5_TAAGGCGA-TAGATCGC_0

description: first_run/Sample_E12_5_TAAGGCGA-TAGATCGC_0


title: Sample_E12_5_TAAGGCGA-CTAAGCCT_0

description: first_run/Sample_E12_5_TAAGGCGA-CTAAGCCT_0


title: Sample_E12_5_TAGGCATG-TAGATCGC_0

description: first_run/Sample_E12_5_TAGGCATG-TAGATCGC_0


title: Sample_E12_5_TAAGGCGA-AAGGAGTA_0

description: first_run/Sample_E12_5_TAAGGCGA-AAGGAGTA_0


title: Sample_E12_5_GTAGAGGA-TAGATCGC_0

description: first_run/Sample_E12_5_GTAGAGGA-TAGATCGC_0


title: Sample_E12_5_GTAGAGGA-TATCCTCT_0

description: first_run/Sample_E12_5_GTAGAGGA-TATCCTCT_0


title: Sample_E12_5_GTAGAGGA-GTAAGGAG_0

description: first_run/Sample_E12_5_GTAGAGGA-GTAAGGAG_0


title: Sample_E12_5_GTAGAGGA-CTCTCTAT_0

description: first_run/Sample_E12_5_GTAGAGGA-CTCTCTAT_0


title: Sample_E12_5_GTAGAGGA-AGAGTAGA_0

description: first_run/Sample_E12_5_GTAGAGGA-AGAGTAGA_0


title: Sample_E12_5_GTAGAGGA-ACTGCATA_0

description: first_run/Sample_E12_5_GTAGAGGA-ACTGCATA_0


title: Sample_E12_5_GGACTCCT-TATCCTCT_0

description: first_run/Sample_E12_5_GGACTCCT-TATCCTCT_0


title: Sample_E12_5_GTAGAGGA-AAGGAGTA_0

description: first_run/Sample_E12_5_GTAGAGGA-AAGGAGTA_0


title: Sample_E12_5_GGACTCCT-TAGATCGC_0

description: first_run/Sample_E12_5_GGACTCCT-TAGATCGC_0


title: Sample_E12_5_GTAGAGGA-CTAAGCCT_0

description: first_run/Sample_E12_5_GTAGAGGA-CTAAGCCT_0


title: Sample_E12_5_TAGGCATG-ACTGCATA_0

description: first_run/Sample_E12_5_TAGGCATG-ACTGCATA_0


title: Sample_E12_5_GGACTCCT-GTAAGGAG_0

description: first_run/Sample_E12_5_GGACTCCT-GTAAGGAG_0


title: Sample_E12_5_GGACTCCT-CTCTCTAT_0

description: first_run/Sample_E12_5_GGACTCCT-CTCTCTAT_0


title: Sample_E12_5_TAAGGCGA-GTAAGGAG_0

description: first_run/Sample_E12_5_TAAGGCGA-GTAAGGAG_0


title: Sample_E12_5_GGACTCCT-ACTGCATA_0

description: first_run/Sample_E12_5_GGACTCCT-ACTGCATA_0


title: Sample_E12_5_GGACTCCT-AGAGTAGA_0

description: first_run/Sample_E12_5_GGACTCCT-AGAGTAGA_0


title: Sample_E12_5_TAAGGCGA-AGAGTAGA_0

description: first_run/Sample_E12_5_TAAGGCGA-AGAGTAGA_0


title: Sample_E12_5_GCTACGCT-GTAAGGAG_0

description: first_run/Sample_E12_5_GCTACGCT-GTAAGGAG_0


title: Sample_E12_5_GCTACGCT-CTCTCTAT_0

description: first_run/Sample_E12_5_GCTACGCT-CTCTCTAT_0


title: Sample_E12_5_GCTACGCT-TATCCTCT_0

description: first_run/Sample_E12_5_GCTACGCT-TATCCTCT_0


title: Sample_E12_5_CTCTCTAC-TATCCTCT_0

description: first_run/Sample_E12_5_CTCTCTAC-TATCCTCT_0


title: Sample_E12_5_CTCTCTAC-GTAAGGAG_0

description: first_run/Sample_E12_5_CTCTCTAC-GTAAGGAG_0


title: Sample_E12_5_GCTACGCT-TAGATCGC_0

description: first_run/Sample_E12_5_GCTACGCT-TAGATCGC_0


title: Sample_E12_5_CTCTCTAC-CTCTCTAT_0

description: first_run/Sample_E12_5_CTCTCTAC-CTCTCTAT_0


title: Sample_E12_5_GCTACGCT-CTAAGCCT_0

description: first_run/Sample_E12_5_GCTACGCT-CTAAGCCT_0


title: Sample_E12_5_GCTACGCT-AAGGAGTA_0

description: first_run/Sample_E12_5_GCTACGCT-AAGGAGTA_0


title: Sample_E12_5_CTCTCTAC-TAGATCGC_0

description: first_run/Sample_E12_5_CTCTCTAC-TAGATCGC_0


title: Sample_E12_5_CTCTCTAC-AAGGAGTA_0

description: first_run/Sample_E12_5_CTCTCTAC-AAGGAGTA_0


title: Sample_E12_5_GGACTCCT-AAGGAGTA_0

description: first_run/Sample_E12_5_GGACTCCT-AAGGAGTA_0


title: Sample_E12_5_GCTACGCT-AGAGTAGA_0

description: first_run/Sample_E12_5_GCTACGCT-AGAGTAGA_0


title: Sample_E12_5_CTCTCTAC-AGAGTAGA_0

description: first_run/Sample_E12_5_CTCTCTAC-AGAGTAGA_0


title: Sample_E12_5_CTCTCTAC-CTAAGCCT_0

description: first_run/Sample_E12_5_CTCTCTAC-CTAAGCCT_0


title: Sample_E12_5_CTCTCTAC-ACTGCATA_0

description: first_run/Sample_E12_5_CTCTCTAC-ACTGCATA_0


title: Sample_E12_5_GGACTCCT-CTAAGCCT_0

description: first_run/Sample_E12_5_GGACTCCT-CTAAGCCT_0


title: Sample_E12_5_GCTACGCT-ACTGCATA_0

description: first_run/Sample_E12_5_GCTACGCT-ACTGCATA_0


title: Sample_E12_5_CGTACTAG-CTAAGCCT_0

description: first_run/Sample_E12_5_CGTACTAG-CTAAGCCT_0


title: Sample_E12_5_CGTACTAG-AGAGTAGA_0

description: first_run/Sample_E12_5_CGTACTAG-AGAGTAGA_0


title: Sample_E12_5_CGTACTAG-CTCTCTAT_0

description: first_run/Sample_E12_5_CGTACTAG-CTCTCTAT_0


title: Sample_E12_5_CGTACTAG-TATCCTCT_0

description: first_run/Sample_E12_5_CGTACTAG-TATCCTCT_0


title: Sample_E12_5_CGAGGCTG-TATCCTCT_0

description: first_run/Sample_E12_5_CGAGGCTG-TATCCTCT_0


title: Sample_E12_5_CGTACTAG-TAGATCGC_0

description: first_run/Sample_E12_5_CGTACTAG-TAGATCGC_0


title: Sample_E12_5_CGTACTAG-AAGGAGTA_0

description: first_run/Sample_E12_5_CGTACTAG-AAGGAGTA_0


title: Sample_E12_5_CGAGGCTG-GTAAGGAG_0

description: first_run/Sample_E12_5_CGAGGCTG-GTAAGGAG_0


title: Sample_E12_5_CGTACTAG-ACTGCATA_0

description: first_run/Sample_E12_5_CGTACTAG-ACTGCATA_0


title: Sample_E12_5_CGAGGCTG-TAGATCGC_0

description: first_run/Sample_E12_5_CGAGGCTG-TAGATCGC_0


title: Sample_E12_5_CGAGGCTG-CTCTCTAT_0

description: first_run/Sample_E12_5_CGAGGCTG-CTCTCTAT_0


title: Sample_E12_5_CGAGGCTG-ACTGCATA_0

description: first_run/Sample_E12_5_CGAGGCTG-ACTGCATA_0


title: Sample_E12_5_CGAGGCTG-AGAGTAGA_0

description: first_run/Sample_E12_5_CGAGGCTG-AGAGTAGA_0


title: Sample_E12_5_CGAGGCTG-CTAAGCCT_0

description: first_run/Sample_E12_5_CGAGGCTG-CTAAGCCT_0


title: Sample_E12_5_CGAGGCTG-AAGGAGTA_0

description: first_run/Sample_E12_5_CGAGGCTG-AAGGAGTA_0


title: Sample_E12_5_CGTACTAG-GTAAGGAG_0

description: first_run/Sample_E12_5_CGTACTAG-GTAAGGAG_0


title: Sample_E12_5_CAGAGAGG-GTAAGGAG_0

description: first_run/Sample_E12_5_CAGAGAGG-GTAAGGAG_0


title: Sample_E12_5_CAGAGAGG-CTCTCTAT_0

description: first_run/Sample_E12_5_CAGAGAGG-CTCTCTAT_0


title: Sample_E12_5_CAGAGAGG-TAGATCGC_0

description: first_run/Sample_E12_5_CAGAGAGG-TAGATCGC_0


title: Sample_E12_5_CAGAGAGG-ACTGCATA_0

description: first_run/Sample_E12_5_CAGAGAGG-ACTGCATA_0


title: Sample_E12_5_CAGAGAGG-CTAAGCCT_0

description: first_run/Sample_E12_5_CAGAGAGG-CTAAGCCT_0


title: Sample_E12_5_AGGCAGAA-TAGATCGC_0

description: first_run/Sample_E12_5_AGGCAGAA-TAGATCGC_0


title: Sample_E12_5_AGGCAGAA-TATCCTCT_0

description: first_run/Sample_E12_5_AGGCAGAA-TATCCTCT_0


title: Sample_E12_5_CAGAGAGG-AGAGTAGA_0

description: first_run/Sample_E12_5_CAGAGAGG-AGAGTAGA_0


title: Sample_E12_5_AGGCAGAA-CTAAGCCT_0

description: first_run/Sample_E12_5_AGGCAGAA-CTAAGCCT_0


title: Sample_E12_5_AGGCAGAA-CTCTCTAT_0

description: first_run/Sample_E12_5_AGGCAGAA-CTCTCTAT_0


title: Sample_E12_5_AGGCAGAA-AGAGTAGA_0

description: first_run/Sample_E12_5_AGGCAGAA-AGAGTAGA_0


title: Sample_E12_5_AGGCAGAA-ACTGCATA_0

description: first_run/Sample_E12_5_AGGCAGAA-ACTGCATA_0


title: Sample_E12_5_AAGAGGCA-TATCCTCT_0

description: first_run/Sample_E12_5_AAGAGGCA-TATCCTCT_0


title: Sample_E12_5_AGGCAGAA-GTAAGGAG_0

description: first_run/Sample_E12_5_AGGCAGAA-GTAAGGAG_0


title: Sample_E12_5_AGGCAGAA-AAGGAGTA_0

description: first_run/Sample_E12_5_AGGCAGAA-AAGGAGTA_0


title: Sample_E12_5_AAGAGGCA-CTCTCTAT_0

description: first_run/Sample_E12_5_AAGAGGCA-CTCTCTAT_0


title: Sample_E12_5_AAGAGGCA-GTAAGGAG_0

description: first_run/Sample_E12_5_AAGAGGCA-GTAAGGAG_0


title: Sample_E12_5_AAGAGGCA-ACTGCATA_0

description: first_run/Sample_E12_5_AAGAGGCA-ACTGCATA_0


title: Sample_E12_5_AAGAGGCA-AGAGTAGA_0

description: first_run/Sample_E12_5_AAGAGGCA-AGAGTAGA_0


title: Sample_E12_5_AAGAGGCA-TAGATCGC_0

description: first_run/Sample_E12_5_AAGAGGCA-TAGATCGC_0


title: Sample_E12_5_CAGAGAGG-TATCCTCT_0

description: first_run/Sample_E12_5_CAGAGAGG-TATCCTCT_0


title: Sample_E12_5_AAGAGGCA-CTAAGCCT_0

description: first_run/Sample_E12_5_AAGAGGCA-CTAAGCCT_0


title: Sample_E12_5_CAGAGAGG-AAGGAGTA_0

description: first_run/Sample_E12_5_CAGAGAGG-AAGGAGTA_0


title: E15_5_96_GTAGAGGA-CTAAGCCT_0


title: E15_5_9_GCTACGCT-TAGATCGC_0


title: E15_5_93_GCTACGCT-CTAAGCCT_0


title: E15_5_94_CGAGGCTG-CTAAGCCT_0


title: E15_5_95_AAGAGGCA-CTAAGCCT_0


title: E15_5_92_CAGAGAGG-CTAAGCCT_0


title: E15_5_91_CTCTCTAC-CTAAGCCT_0


title: E15_5_8_CAGAGAGG-TAGATCGC_0


title: E15_5_89_GGACTCCT-CTAAGCCT_0


title: E15_5_90_TAGGCATG-CTAAGCCT_0


title: E15_5_86_CGTACTAG-CTAAGCCT_0


title: E15_5_83_AAGAGGCA-AAGGAGTA_0


title: E15_5_81_GCTACGCT-AAGGAGTA_0


title: E15_5_82_CGAGGCTG-AAGGAGTA_0


title: E15_5_84_GTAGAGGA-AAGGAGTA_0


title: E15_5_88_TCCTGAGC-CTAAGCCT_0


title: E15_5_7_CTCTCTAC-TAGATCGC_0


title: E15_5_79_CTCTCTAC-AAGGAGTA_0


title: E15_5_77_GGACTCCT-AAGGAGTA_0


title: E15_5_76_TCCTGAGC-AAGGAGTA_0


title: E15_5_75_AGGCAGAA-AAGGAGTA_0


title: Sample_E12_5_AAGAGGCA-AAGGAGTA_0

description: first_run/Sample_E12_5_AAGAGGCA-AAGGAGTA_0


title: E15_5_74_CGTACTAG-AAGGAGTA_0


title: E15_5_73_TAAGGCGA-AAGGAGTA_0


title: E15_5_72_GTAGAGGA-ACTGCATA_0


title: E15_5_70_CGAGGCTG-ACTGCATA_0


title: E15_5_87_AGGCAGAA-CTAAGCCT_0


title: E15_5_6_TAGGCATG-TAGATCGC_0


title: E15_5_66_TAGGCATG-ACTGCATA_0


title: E15_5_69_GCTACGCT-ACTGCATA_0


title: E15_5_68_CAGAGAGG-ACTGCATA_0


title: E15_5_71_AAGAGGCA-ACTGCATA_0


title: E15_5_64_TCCTGAGC-ACTGCATA_0


title: E15_5_85_TAAGGCGA-CTAAGCCT_0


title: E15_5_65_GGACTCCT-ACTGCATA_0


title: E15_5_80_CAGAGAGG-AAGGAGTA_0


title: E15_5_61_TAAGGCGA-ACTGCATA_0


title: E15_5_5_GGACTCCT-TAGATCGC_0


title: E15_5_58_CGAGGCTG-GTAAGGAG_0


title: E15_5_60_GTAGAGGA-GTAAGGAG_0


title: E15_5_78_TAGGCATG-AAGGAGTA_0


title: E15_5_59_AAGAGGCA-GTAAGGAG_0


title: E15_5_56_CAGAGAGG-GTAAGGAG_0


title: E15_5_55_CTCTCTAC-GTAAGGAG_0


title: E15_5_53_GGACTCCT-GTAAGGAG_0


title: E15_5_54_TAGGCATG-GTAAGGAG_0


title: E15_5_52_TCCTGAGC-GTAAGGAG_0


title: E15_5_51_AGGCAGAA-GTAAGGAG_0


title: E15_5_67_CTCTCTAC-ACTGCATA_0


title: E15_5_50_CGTACTAG-GTAAGGAG_0


title: E15_5_63_AGGCAGAA-ACTGCATA_0


title: E15_5_48_GTAGAGGA-AGAGTAGA_0


title: E15_5_47_AAGAGGCA-AGAGTAGA_0


title: E15_5_49_TAAGGCGA-GTAAGGAG_0


title: E15_5_4_TCCTGAGC-TAGATCGC_0


title: E15_5_62_CGTACTAG-ACTGCATA_0


title: E15_5_43_CTCTCTAC-AGAGTAGA_0


title: E15_5_42_TAGGCATG-AGAGTAGA_0


title: E15_5_46_CGAGGCTG-AGAGTAGA_0


title: E15_5_45_GCTACGCT-AGAGTAGA_0


title: E15_5_40_TCCTGAGC-AGAGTAGA_0


title: E15_5_3_AGGCAGAA-TAGATCGC_0


title: E15_5_39_AGGCAGAA-AGAGTAGA_0


title: E15_5_37_TAAGGCGA-AGAGTAGA_0


title: E15_5_41_GGACTCCT-AGAGTAGA_0


title: E15_5_38_CGTACTAG-AGAGTAGA_0


title: E15_5_35_AAGAGGCA-TATCCTCT_0


title: E15_5_36_GTAGAGGA-TATCCTCT_0


title: E15_5_34_CGAGGCTG-TATCCTCT_0


title: E15_5_32_CAGAGAGG-TATCCTCT_0


title: E15_5_33_GCTACGCT-TATCCTCT_0


title: E15_5_31_CTCTCTAC-TATCCTCT_0


title: E15_5_30_TAGGCATG-TATCCTCT_0


title: E15_5_2_CGTACTAG-TAGATCGC_0


title: E15_5_28_TCCTGAGC-TATCCTCT_0


title: E15_5_29_GGACTCCT-TATCCTCT_0


title: E15_5_26_CGTACTAG-TATCCTCT_0


title: E15_5_27_AGGCAGAA-TATCCTCT_0


title: E15_5_22_CGAGGCTG-CTCTCTAT_0


title: E15_5_24_GTAGAGGA-CTCTCTAT_0


title: E15_5_44_CAGAGAGG-AGAGTAGA_0


title: E15_5_19_CTCTCTAC-CTCTCTAT_0


title: E15_5_25_TAAGGCGA-TATCCTCT_0


title: E15_5_20_CAGAGAGG-CTCTCTAT_0


title: E15_5_1_TAAGGCGA-TAGATCGC_0


title: E15_5_57_GCTACGCT-GTAAGGAG_0


title: E15_5_16_TCCTGAGC-CTCTCTAT_0


title: E15_5_17_GGACTCCT-CTCTCTAT_0


title: E15_5_15_AGGCAGAA-CTCTCTAT_0


title: E15_5_23_AAGAGGCA-CTCTCTAT_0


title: E15_5_13_TAAGGCGA-CTCTCTAT_0


title: Sample_E14_5_TAGGCATG-AAGGAGTA_0

description: first_run/Sample_E14_5_TAGGCATG-AAGGAGTA_0


title: E15_5_14_CGTACTAG-CTCTCTAT_0


title: E15_5_21_GCTACGCT-CTCTCTAT_0


title: E15_5_11_AAGAGGCA-TAGATCGC_0


title: E15_5_12_GTAGAGGA-TAGATCGC_0


title: E13_5_8_CAGAGAGG-TAGATCGC_0


title: E13_5_7_CTCTCTAC-TAGATCGC_0


title: E13_5_9_GCTACGCT-TAGATCGC_0


title: E13_5_71_CAGAGAGG-CTAAGCCT_0


title: E13_5_72_GCTACGCT-CTAAGCCT_0


title: E13_5_70_CTCTCTAC-CTAAGCCT_0


title: E13_5_69_TAGGCATG-CTAAGCCT_0


title: E13_5_6_TAGGCATG-TAGATCGC_0


title: E13_5_68_GGACTCCT-CTAAGCCT_0


title: E15_5_18_TAGGCATG-CTCTCTAT_0


title: E13_5_66_AGGCAGAA-CTAAGCCT_0


title: E13_5_67_TCCTGAGC-CTAAGCCT_0


title: E13_5_65_CGTACTAG-CTAAGCCT_0


title: E13_5_64_TAAGGCGA-CTAAGCCT_0


title: E13_5_63_GCTACGCT-AAGGAGTA_0


title: E15_5_10_CGAGGCTG-TAGATCGC_0


title: E13_5_62_CAGAGAGG-AAGGAGTA_0


title: E13_5_59_GGACTCCT-AAGGAGTA_0


title: E13_5_61_CTCTCTAC-AAGGAGTA_0


title: E13_5_52_CTCTCTAC-ACTGCATA_0


title: E13_5_58_TCCTGAGC-AAGGAGTA_0


title: E13_5_54_GCTACGCT-ACTGCATA_0


title: E13_5_5_GGACTCCT-TAGATCGC_0


title: E13_5_53_CAGAGAGG-ACTGCATA_0


title: E13_5_50_GGACTCCT-ACTGCATA_0


title: E13_5_51_TAGGCATG-ACTGCATA_0


title: E13_5_55_TAAGGCGA-AAGGAGTA_0


title: E13_5_48_AGGCAGAA-ACTGCATA_0


title: E13_5_60_TAGGCATG-AAGGAGTA_0


title: E13_5_4_TCCTGAGC-TAGATCGC_0


title: E13_5_47_CGTACTAG-ACTGCATA_0


title: E13_5_57_AGGCAGAA-AAGGAGTA_0


title: E13_5_56_CGTACTAG-AAGGAGTA_0


title: E13_5_43_CTCTCTAC-GTAAGGAG_0


title: E13_5_49_TCCTGAGC-ACTGCATA_0


title: E13_5_44_CAGAGAGG-GTAAGGAG_0


title: E13_5_45_GCTACGCT-GTAAGGAG_0


title: E13_5_41_GGACTCCT-GTAAGGAG_0


title: E13_5_40_TCCTGAGC-GTAAGGAG_0


title: E13_5_3_AGGCAGAA-TAGATCGC_0


title: E13_5_42_TAGGCATG-GTAAGGAG_0


title: E13_5_39_AGGCAGAA-GTAAGGAG_0


title: E13_5_38_CGTACTAG-GTAAGGAG_0


title: E13_5_33_TAGGCATG-AGAGTAGA_0


title: E13_5_34_CTCTCTAC-AGAGTAGA_0


title: E13_5_35_CAGAGAGG-AGAGTAGA_0


title: E13_5_37_TAAGGCGA-GTAAGGAG_0


title: E13_5_2_CGTACTAG-TAGATCGC_0


title: E13_5_36_GCTACGCT-AGAGTAGA_0


title: E13_5_32_GGACTCCT-AGAGTAGA_0


title: E13_5_29_CGTACTAG-AGAGTAGA_0


title: E13_5_30_AGGCAGAA-AGAGTAGA_0


title: E13_5_27_GCTACGCT-TATCCTCT_0


title: HDF infected VZV VarilRix

city: Seoul

first: Ok Sarah

last: Shin

address: 148, Gurodongro, Gurogu

institute: Korea Univ.

description: HDF

data_processing:
Sequencing Quality assessment refer to Wang L, Wang S, Li W., RSeQC: Quality Control of RNA-seq experiments. Bioinformatics. 2012 Jun 27 and Simon Andrews. FastQC: A quality control tool for high throughput sequence data.
Gene expression level was measured according to Wang L, Feng Z, Wang X, Wang X, Zhang X. Bioinformatics. 2010 Jan 1;26(1):136-8. Epub 2009 Oct 24. DEGseq: an R package for identifying differentially expressed genes from RNA-seq data.
Alignment was performed according to Li H, Durbin R. Bioinformatics. 2010 Mar 1;26(5):589-95. Epub 2010 Jan 15. Fast and accurate long-read alignment with Burrows-Wheeler transform.
Genome_build: GRCh37
Supplementary_files_format_and_content: excel files include GeneName, GeneDescription, Value_1, Value_2, log2foldchange, p_value, q_value.

source_name: Skin

growth_protocol: Normal HDFs(Human Dermal Fibroblast) were infected with VZV strains for 2 days on 12well (MOI=0.01) and RNA was harvested using TRI-Zol reagent.

extract_protocol:
Cell were lysed via Trizol; RNA isolated using RNA prep kit(Direct-zol™ RNA MiniPrep Plus)
TruSeq RNA Library Prep Kit

treatment_protocol: Plated HDF cells cultured in growth media containing virus for 1hour (for attachment); media changed to growth media(RPMI, 15% FBS, 1% Penicillin/Streptomycin)

value: Skin Fibroblast

tag: viral strain

value: VarilRix


title: HDF infected VZV Suduvax CA

description: HDF

tag: cell type

value: Sudavax CA


title: E13_5_26_CAGAGAGG-TATCCTCT_0


title: E13_5_28_TAAGGCGA-AGAGTAGA_0


title: HDF infected VZV YC01 -high

description:
HDF
YC01-high VZV strain is derived from YC01-low strain and passaged for more than >100 times. YC01-high contains vaccine type mutations and is similar to VZV live attenuated vaccine strain.


title: HDF infected VZV Suduvax CF

description: HDF

value: Sudavax CF


title: E13_5_46_TAAGGCGA-ACTGCATA_0


title: E13_5_24_TAGGCATG-TATCCTCT_0


title: Mock

description: HDF


title: E13_5_23_GGACTCCT-TATCCTCT_0


title: E13_5_22_TCCTGAGC-TATCCTCT_0


title: HDF infected VZV YC01-low

description:
HDF
YC01-low is a clinical VZV strain isolated from Shingles patient and cultured at low passage.


title: E13_5_21_AGGCAGAA-TATCCTCT_0


title: E13_5_20_CGTACTAG-TATCCTCT_0


title: CL-15

city: Durham

first: Integrative

last: Bioinformatics

state: NC

address: 111 TW Alexander Drive

department: BCBB

institute: NIEHS

description:
198CC_S
processed data file: CC_NormalizedReadCounts.xls
13689X38_161114_D00294_0271_ACAATKANXX_5

data_processing:
Fastq files were aligned to the human Hg38 reference genome with the STAR aligner using the Web interface application Oasis (https://oasis.dzne.de/index.php)
Raw read count files for known and novel small RNAs were generated using miRDeep2 as part of the online Oasis sRNA Detection application
Normalized read counts (counts per million reads (CPM)) and differentially expressed genes were determined using DESeq2 as part of the Oasis DE Analysis application
Genome_build: Homo sapiens Hg38
Supplementary_files_format_and_content: Excel file with small RNA IDs, predicted structure, chromosome coordinates, start and stop, strand and normalized read counts (CPM)

source_name: Colon

extract_protocol:
DirectZOL (ZymoResearch)
Illumina TruSeq Small RNA Sample Prep (10613 experiment) and NEBNext Multiplex Small RNA Library Prep for Illumina (11961 and 13689 experiments)

tag: cohort

value: Control

tag: tissue subtype

value: Control left colon


title: CL-13

description:
187CC_S
processed data file: CC_NormalizedReadCounts.xls
13689X27_161114_D00294_0271_ACAATKANXX_5


title: CL-14

description:
196CC_S
processed data file: CC_NormalizedReadCounts.xls
13689X36_161114_D00294_0271_ACAATKANXX_5


title: E13_5_1_TAAGGCGA-TAGATCGC_0

tag: tissue


title: E13_5_31_TCCTGAGC-AGAGTAGA_0


title: E13_5_19_TAAGGCGA-TATCCTCT_0


title: E13_5_25_CTCTCTAC-TATCCTCT_0


title: E13_5_17_CAGAGAGG-CTCTCTAT_0


title: CL-10

description:
183CC_S
processed data file: CC_NormalizedReadCounts.xls
13689X7_161114_D00294_0271_ACAATKANXX_4


title: CL-11

description:
312CC_S
processed data file: CC_NormalizedReadCounts.xls
13689X22_161114_D00294_0271_ACAATKANXX_4


title: E13_5_16_CTCTCTAC-CTCTCTAT_0


title: CL-8

description:
179CC_S
processed data file: CC_NormalizedReadCounts.xls
13689X3_161114_D00294_0271_ACAATKANXX_4


title: E13_5_15_TAGGCATG-CTCTCTAT_0


title: E13_5_14_GGACTCCT-CTCTCTAT_0


title: CL-7

description:
176CC_S
processed data file: CC_NormalizedReadCounts.xls
11961X35_151207_D00550_0309_BC8AP8ANXX_8


title: E13_5_13_TCCTGAGC-CTCTCTAT_0


title: CL-5

description:
158CC_S
processed data file: CC_NormalizedReadCounts.xls
11961X31_151216_D00550_0312_BC8B1RANXX_8


title: E13_5_12_AGGCAGAA-CTCTCTAT_0


title: CL-4

description:
154CC_S
processed data file: CC_NormalizedReadCounts.xls
11961X29_151216_D00550_0312_BC8B1RANXX_8


title: E13_5_11_CGTACTAG-CTCTCTAT_0


title: CL-3

description:
81CC_S
processed data file: CC_NormalizedReadCounts.xls
11961X6_151207_D00550_0309_BC8AP8ANXX_8


title: CL-1

description:
69CC_S
processed data file: CC_NormalizedReadCounts.xls
11961X2_151210_D00294_0212_AC8B1PANXX_8


title: E11_5_9_GCTACGCT-TAGATCGC_0


title: E11_5_8_CAGAGAGG-TAGATCGC_0


title: CR-15

description:
198CC_A
processed data file: CC_NormalizedReadCounts.xls
13689X39_161114_D00294_0271_ACAATKANXX_5

value: Control right colon


title: CL-12

description:
186CC_S
processed data file: CC_NormalizedReadCounts.xls
13689X25_161114_D00294_0271_ACAATKANXX_5


title: CR-14

description:
196CC_A
processed data file: CC_NormalizedReadCounts.xls
13689X37_161114_D00294_0271_ACAATKANXX_5


title: E11_5_80_CGAGGCTG-CTAAGCCT_0


title: E13_5_18_GCTACGCT-CTCTCTAT_0


title: E11_5_7_CTCTCTAC-TAGATCGC_0


title: CR-13

description:
187CC_A
processed data file: CC_NormalizedReadCounts.xls
13689X28_161114_D00294_0271_ACAATKANXX_5


title: CL-2

description:
71CC_S
processed data file: CC_NormalizedReadCounts.xls
11961X4_151210_D00294_0212_AC8B1PANXX_8


title: E13_5_10_TAAGGCGA-CTCTCTAT_0


title: CL-9

description:
181CC_S
processed data file: CC_NormalizedReadCounts.xls
13689X5_161114_D00294_0271_ACAATKANXX_4


title: E11_5_79_GCTACGCT-CTAAGCCT_0


title: E11_5_78_CAGAGAGG-CTAAGCCT_0


title: CR-12

description:
186CC_A
processed data file: CC_NormalizedReadCounts.xls
13689X26_161114_D00294_0271_ACAATKANXX_5


title: E11_5_77_CTCTCTAC-CTAAGCCT_0


title: CL-6

description:
164CC_S
processed data file: CC_NormalizedReadCounts.xls
11961X33_151216_D00550_0312_BC8B1RANXX_8


title: E11_5_76_TAGGCATG-CTAAGCCT_0


title: CR-9

description:
181CC_A
processed data file: CC_NormalizedReadCounts.xls
13689X6_161114_D00294_0271_ACAATKANXX_4


title: CR-6

description:
164CC_A
processed data file: CC_NormalizedReadCounts.xls
11961X32_151216_D00550_0312_BC8B1RANXX_8


title: CR-7

description:
176CC_A
processed data file: CC_NormalizedReadCounts.xls
11961X34_151207_D00550_0309_BC8AP8ANXX_8


title: CR-8

description:
179CC_A
processed data file: CC_NormalizedReadCounts.xls
13689X4_161114_D00294_0271_ACAATKANXX_4


title: E11_5_73_AGGCAGAA-CTAAGCCT_0


title: E11_5_71_TAAGGCGA-CTAAGCCT_0


title: E11_5_70_CGAGGCTG-AAGGAGTA_0


title: CR-4

description:
154CC_A
processed data file: CC_NormalizedReadCounts.xls
11961X28_151216_D00550_0312_BC8B1RANXX_8


title: CR-3

description:
81CC_A
processed data file: CC_NormalizedReadCounts.xls
11961X5_151207_D00550_0309_BC8AP8ANXX_8


title: CR-2

description:
71CC_A
processed data file: CC_NormalizedReadCounts.xls
11961X3_151210_D00294_0212_AC8B1PANXX_8


title: CR-1

description:
69CC_T
processed data file: CC_NormalizedReadCounts.xls
11961X1_151210_D00294_0212_AC8B1PANXX_8


title: E11_5_6_TAGGCATG-TAGATCGC_0


title: UL-11

description:
313UC_S
processed data file: HP_NormalizedReadCounts.xls
13689X43_161114_D00294_0271_ACAATKANXX_5

value: Sporadic

value: Uninvolved left colon


title: E11_5_67_CTCTCTAC-AAGGAGTA_0


title: E11_5_66_TAGGCATG-AAGGAGTA_0


title: E11_5_68_CAGAGAGG-AAGGAGTA_0


title: UL-10

description:
195UC_S
processed data file: HP_NormalizedReadCounts.xls
13689X33_161114_D00294_0271_ACAATKANXX_5


title: UL-9

description:
189UC_S
processed data file: AP_NormalizedReadCounts.xls
13689X31_161114_D00294_0271_ACAATKANXX_5


title: CR-5

description:
158CC_A
processed data file: CC_NormalizedReadCounts.xls
11961X30_151216_D00550_0312_BC8B1RANXX_8


title: E11_5_69_GCTACGCT-AAGGAGTA_0


title: CR-11

description:
312CC_A
processed data file: CC_NormalizedReadCounts.xls
13689X23_161114_D00294_0271_ACAATKANXX_4


title: E11_5_64_TCCTGAGC-AAGGAGTA_0


title: E11_5_65_GGACTCCT-AAGGAGTA_0


title: E11_5_75_GGACTCCT-CTAAGCCT_0


title: UL-7

description:
303UC_S
processed data file: HP_NormalizedReadCounts.xls
13689X13_161114_D00294_0271_ACAATKANXX_4


title: E11_5_74_TCCTGAGC-CTAAGCCT_0


title: UL-8

description:
309UC_S
processed data file: HP_NormalizedReadCounts.xls
13689X19_161114_D00294_0271_ACAATKANXX_4


title: E11_5_63_AGGCAGAA-AAGGAGTA_0


title: CR-10

description:
183CC_A
processed data file: CC_NormalizedReadCounts.xls
13689X8_161114_D00294_0271_ACAATKANXX_4


title: UL-6

description:
178UC_S
processed data file: AP_NormalizedReadCounts.xls
13689X2_161114_D00294_0271_ACAATKANXX_4


title: E11_5_72_CGTACTAG-CTAAGCCT_0


title: E11_5_61_TAAGGCGA-AAGGAGTA_0


title: E11_5_62_CGTACTAG-AAGGAGTA_0


title: UL-4

description:
105UC_S
processed data file: HP_NormalizedReadCounts.xls
11961X12_151210_D00294_0212_AC8B1PANXX_8


title: E11_5_60_CGAGGCTG-ACTGCATA_0


title: UL-3

description:
76UC_S
processed data file: HP_NormalizedReadCounts.xls
11961X11_151210_D00294_0212_AC8B1PANXX_8


title: E11_5_5_GGACTCCT-TAGATCGC_0


title: UL-2

description:
111UC_S
processed data file: HP_NormalizedReadCounts.xls
10613X11_140320_SN141_0774_AC3RBEACXX_8


title: E11_5_58_CAGAGAGG-ACTGCATA_0


title: UL-1

description:
100UC_S
processed data file: SSAP_NormalizedReadCounts.xls
10613X9_140320_SN141_0774_AC3RBEACXX_8


title: E11_5_57_CTCTCTAC-ACTGCATA_0


title: UR-23

description:
314UC_A
processed data file: SSAP_NormalizedReadCounts.xls
13689X47_161114_D00294_0271_ACAATKANXX_5

value: Uninvolved right colon


title: E11_5_56_TAGGCATG-ACTGCATA_0


title: UR-22

description:
300UC_A
processed data file: AP_NormalizedReadCounts.xls
13689X42_161114_D00294_0271_ACAATKANXX_5


title: E11_5_54_TCCTGAGC-ACTGCATA_0


title: UR-20

description:
304UC_A
processed data file: SSAP_NormalizedReadCounts.xls
13689X18_161114_D00294_0271_ACAATKANXX_4


title: UR-19

description:
301UC_A
processed data file: AP_NormalizedReadCounts.xls
13689X12_161114_D00294_0271_ACAATKANXX_4


title: E11_5_55_GGACTCCT-ACTGCATA_0


title: UR-17

description:
177UC_A
processed data file: AP_NormalizedReadCounts.xls
11961X43_151216_D00550_0312_BC8B1RANXX_8


title: E11_5_53_AGGCAGAA-ACTGCATA_0


title: E11_5_52_CGTACTAG-ACTGCATA_0


title: UR-18

description:
184UC_A
processed data file: AP_NormalizedReadCounts.xls
13689X9_161114_D00294_0271_ACAATKANXX_4


title: UR-16

description:
163UC_A
processed data file: HP_NormalizedReadCounts.xls
11961X41_151216_D00550_0312_BC8B1RANXX_8


title: UL-5

description:
168UC_S
processed data file: AP_NormalizedReadCounts.xls
11961X42_151216_D00550_0312_BC8B1RANXX_8


title: UR-15

description:
161UC_A
processed data file: HP_NormalizedReadCounts.xls
11961X40_151216_D00550_0312_BC8B1RANXX_8


title: E11_5_50_CGAGGCTG-GTAAGGAG_0


title: E11_5_51_TAAGGCGA-ACTGCATA_0


title: E11_5_4_TCCTGAGC-TAGATCGC_0


title: UR-13

description:
156UC_A
processed data file: SSAP_NormalizedReadCounts.xls
11961X38_151216_D00550_0312_BC8B1RANXX_8


title: E11_5_49_GCTACGCT-GTAAGGAG_0


title: UR-14

description:
157UC_A
processed data file: SSAP_NormalizedReadCounts.xls
11961X39_151216_D00550_0312_BC8B1RANXX_8


title: E11_5_59_GCTACGCT-ACTGCATA_0


title: UR-11

description:
103UC_A
processed data file: AP_NormalizedReadCounts.xls
11961X15_151207_D00550_0309_BC8AP8ANXX_8


title: E11_5_46_TAGGCATG-GTAAGGAG_0


title: UR-12

description:
104UC_A
processed data file: AP_NormalizedReadCounts.xls
11961X36_151207_D00550_0309_BC8AP8ANXX_8


title: E11_5_47_CTCTCTAC-GTAAGGAG_0


title: UR-10

description:
102UC_A
processed data file: AP_NormalizedReadCounts.xls
11961X14_151210_D00294_0212_AC8B1PANXX_8


title: E11_5_45_GGACTCCT-GTAAGGAG_0


title: UR-21

description:
195UC_A
processed data file: SSAP_NormalizedReadCounts.xls
13689X35_161114_D00294_0271_ACAATKANXX_5


title: UR-9

description:
151UC_A
processed data file: HP_NormalizedReadCounts.xls
11961X13_151210_D00294_0212_AC8B1PANXX_8


title: E11_5_43_AGGCAGAA-GTAAGGAG_0


title: E11_5_42_CGTACTAG-GTAAGGAG_0


title: E11_5_44_TCCTGAGC-GTAAGGAG_0


title: E11_5_39_GCTACGCT-AGAGTAGA_0


title: E11_5_3_AGGCAGAA-TAGATCGC_0


title: UR-5

description:
13UC_C
processed data file: SSAP_NormalizedReadCounts.xls
11961X8_151207_D00550_0309_BC8AP8ANXX_8

value: Serrated Polyposis


title: E11_5_41_TAAGGCGA-GTAAGGAG_0


title: UR-6

description:
14UC_A
processed data file: SSAP_NormalizedReadCounts.xls
11961X9_151210_D00294_0212_AC8B1PANXX_8


title: UR-3

description:
15UC_T
processed data file: SSAP_NormalizedReadCounts.xls
10613X5_140320_SN141_0774_AC3RBEACXX_8


title: E11_5_40_CGAGGCTG-AGAGTAGA_0


title: E11_5_48_CAGAGAGG-GTAAGGAG_0


title: UR-8

description:
152UC_A
processed data file: SSAP_NormalizedReadCounts.xls
11961X37_151207_D00550_0309_BC8AP8ANXX_8


title: E11_5_38_CAGAGAGG-AGAGTAGA_0


title: E11_5_36_TAGGCATG-AGAGTAGA_0


title: AP-14

description:
300AP_C
processed data file: AP_NormalizedReadCounts.xls
13689X41_161114_D00294_0271_ACAATKANXX_5

value: Adenomatous polyp


title: E11_5_37_CTCTCTAC-AGAGTAGA_0


title: UR-2

description:
13UC_A
processed data file: SSAP_NormalizedReadCounts.xls
10613X3_140320_SN141_0774_AC3RBEACXX_8


title: AP-13

description:
300AP_A
processed data file: AP_NormalizedReadCounts.xls
13689X40_161114_D00294_0271_ACAATKANXX_5


title: UR-1

description:
11UC_A
processed data file: SSAP_NormalizedReadCounts.xls
10613X1_140320_SN141_0774_AC3RBEACXX_8


title: UR-4

description:
11UC_T
processed data file: SSAP_NormalizedReadCounts.xls
11961X7_151207_D00550_0309_BC8AP8ANXX_8


title: E11_5_35_GGACTCCT-AGAGTAGA_0


title: E11_5_34_TCCTGAGC-AGAGTAGA_0


title: E11_5_33_AGGCAGAA-AGAGTAGA_0


title: E11_5_32_CGTACTAG-AGAGTAGA_0


title: E11_5_31_TAAGGCGA-AGAGTAGA_0


title: AP-10

description:
301AP_A
processed data file: AP_NormalizedReadCounts.xls
13689X11_161114_D00294_0271_ACAATKANXX_4


title: AP-9

description:
184AP_T
processed data file: AP_NormalizedReadCounts.xls
13689X10_161114_D00294_0271_ACAATKANXX_4


title: AP-8

description:
178AP_D
processed data file: AP_NormalizedReadCounts.xls
13689X1_161114_D00294_0271_ACAATKANXX_4


title: AP-12

description:
189AP_S
processed data file: AP_NormalizedReadCounts.xls
13689X30_161114_D00294_0271_ACAATKANXX_5


title: UR-7

description:
17UC_A
processed data file: SSAP_NormalizedReadCounts.xls
11961X10_151210_D00294_0212_AC8B1PANXX_8


title: AP-7

description:
177AP_T
processed data file: AP_NormalizedReadCounts.xls
11961X54_151216_D00550_0312_BC8B1RANXX_8


title: E11_5_26_TAGGCATG-TATCCTCT_0


title: E11_5_27_CTCTCTAC-TATCCTCT_0


title: E11_5_25_GGACTCCT-TATCCTCT_0


title: E11_5_29_GCTACGCT-TATCCTCT_0


title: AP-3

description:
103AP_T
processed data file: AP_NormalizedReadCounts.xls
11961X27_151207_D00550_0309_BC8AP8ANXX_8


title: AP-5

description:
104AP_T
processed data file: AP_NormalizedReadCounts.xls
11961X52_151207_D00550_0309_BC8AP8ANXX_8


title: AP-6

description:
168AP_R
processed data file: AP_NormalizedReadCounts.xls
11961X53_151216_D00550_0312_BC8B1RANXX_8


title: E11_5_2_CGTACTAG-TAGATCGC_0


title: E11_5_24_TCCTGAGC-TATCCTCT_0


title: AP-4

description:
104AP_A
processed data file: AP_NormalizedReadCounts.xls
11961X51_151207_D00550_0309_BC8AP8ANXX_8


title: E11_5_23_AGGCAGAA-TATCCTCT_0


title: AP-2

description:
103AP_A
processed data file: AP_NormalizedReadCounts.xls
11961X26_151207_D00550_0309_BC8AP8ANXX_8


title: HP-13

description:
195HP_R
processed data file: HP_NormalizedReadCounts.xls
13689X32_161114_D00294_0271_ACAATKANXX_5

value: Hyperplastic polyp


title: AP-11

description:
189AP_D
processed data file: AP_NormalizedReadCounts.xls
13689X29_161114_D00294_0271_ACAATKANXX_5


title: E11_5_21_TAAGGCGA-TATCCTCT_0


title: HP-14

description:
313HP_S
processed data file: HP_NormalizedReadCounts.xls
13689X44_161114_D00294_0271_ACAATKANXX_5


title: E11_5_22_CGTACTAG-TATCCTCT_0


title: AP-1

description:
102AP_T
processed data file: AP_NormalizedReadCounts.xls
11961X25_151210_D00294_0212_AC8B1PANXX_8


title: HP-12

description:
317HP_R
processed data file: HP_NormalizedReadCounts.xls
13689X24_161114_D00294_0271_ACAATKANXX_4


title: E11_5_20_CGAGGCTG-CTCTCTAT_0


title: E11_5_1_TAAGGCGA-TAGATCGC_0


title: HP-11

description:
309HP_R
processed data file: HP_NormalizedReadCounts.xls
13689X20_161114_D00294_0271_ACAATKANXX_4


title: E11_5_30_CGAGGCTG-TATCCTCT_0


title: E11_5_19_GCTACGCT-CTCTCTAT_0


title: HP-9

description:
163HP_T
processed data file: HP_NormalizedReadCounts.xls
11961X50_151216_D00550_0312_BC8B1RANXX_8


title: HP-8

description:
161HP_C
processed data file: HP_NormalizedReadCounts.xls
11961X49_151216_D00550_0312_BC8B1RANXX_8


title: E11_5_18_CAGAGAGG-CTCTCTAT_0


title: E11_5_17_CTCTCTAC-CTCTCTAT_0